CAMKK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | T455 | Sugiyama | SHTN1 KIAA1598 | KPESSKGCEsAVDELKGILGtLNKSTSSRsLKsLDPENsEt |
| A0MZ66 | T501 | Sugiyama | SHTN1 KIAA1598 | LRRRKVtAEADsssPtGILAtsEsKsMPVLGsVssVTKTAL |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| O00429 | S44 | Sugiyama | DNM1L DLP1 DRP1 | QLPQIVVVGTQSSGKSsVLEsLVGRDLLPRGTGIVTRRPLI |
| O14530 | T21 | Sugiyama | TXNDC9 APACD | MEADASVDMFSKVLEHQLLQtTKLVEEHLDSEIQKLDQMDE |
| O14910 | S135 | Sugiyama | LIN7A MALS1 VELI1 | DEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGDQL |
| O43390 | T134 | Sugiyama | HNRNPR HNRPR | KVQESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O43399 | T146 | Sugiyama | TPD52L2 | yKKTQETLsQAGQKtsAALstVGsAIsRKLGDMRNsAtFKs |
| O43423 | T101 | Sugiyama | ANP32CP PP32R1 | EKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCEV |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60271 | T191 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | MEHLERTKLHQLsGsDQLEstAHsRIRKERPIsLGIFPLPA |
| O60506 | T131 | Sugiyama | SYNCRIP HNRPQ NSAP1 | KVADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O60664 | S175 | Sugiyama | PLIN3 M6PRBP1 TIP47 | RGAVQSGVDKTKsVVtGGVQsVMGsRLGQMVLsGVDtVLGK |
| O60664 | S179 | Sugiyama | PLIN3 M6PRBP1 TIP47 | QSGVDKTKsVVtGGVQsVMGsRLGQMVLsGVDtVLGKsEEW |
| O75116 | T573 | Sugiyama | ROCK2 KIAA0619 | STEKVNQLQRQLDEtNALLRtESDTAARLRKTQAESSKQIQ |
| O75390 | S83 | Sugiyama | CS | ITVDMMYGGMRGMKGLVyEtsVLDPDEGIRFRGFsIPECQK |
| O75821 | T206 | Sugiyama | EIF3G EIF3S4 | LGLstGEKEKLPGELEPVQAtQNKtGKYVPPsLRDGAsRRG |
| O75914 | T119 | Sugiyama | PAK3 OPHN3 | QMCPGKLPEGIPEQWARLLQtsNItKLEQKKNPQAVLDVLK |
| O95155 | T95 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | RsQssEGVssLsssPsNsLEtQsQsLsRsQsMDIDGVSCEK |
| O95626 | T105 | Sugiyama | ANP32D PP32R2 | EKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCEV |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| O95816 | S31 | Sugiyama | BAG2 | NEGRFCRsssMADRsSRLLEsLDQLELRVEALREAATAVEQ |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00338 | T95 | Sugiyama | LDHA PIG19 | PKIVSGKDyNVTANsKLVIItAGARQQEGEsRLNLVQRNVN |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P04040 | T29 | Sugiyama | CAT | SDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRGP |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | T65 | Sugiyama | ALDOA ALDA | QsIGtENtEENRRFyRQLLLtADDRVNPCIGGVILFHETLY |
| P04083 | T172 | Sugiyama | ANXA1 ANX1 LPC1 | INRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDF |
| P04083 | T223 | Sugiyama | ANXA1 ANX1 LPC1 | ARALyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKY |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S176 | Sugiyama | HSPB1 HSP27 HSP28 | sLsPEGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGPEA |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05198 | T281 | Sugiyama | EIF2S1 EIF2A | KIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAEVD |
| P05387 | S29 | Sugiyama | RPLP2 D11S2243E RPP2 | LAALGGNssPsAKDIKKILDsVGIEADDDRLNKVIsELNGK |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P05787 | T153 | Sugiyama | KRT8 CYK8 | RSNMDNMFESYINNLRRQLEtLGQEKLKLEAELGNMQGLVE |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06744 | T248 | Sugiyama | GPI | WFLQAAKDPSAVAKHFVALstNttKVKEFGIDPQNMFEFWD |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07237 | T453 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | EAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKFLESG |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07711 | T332 | Sugiyama | CTSL CTSL1 | VKMAKDRRNHCGIAsAAsyPtV___________________ |
| P07814 | T1506 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LCELQPGAKCVCGKNPAKyytLFGRsy______________ |
| P07814 | T746 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | NETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVRE |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P07900 | T109 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LtIVDtGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P07900 | T645 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKDLVIL |
| P08195 | S403 | Sugiyama | SLC3A2 MDU1 | SDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQYL |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S535 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| P08238 | T104 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LtLVDtGIGMtKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | T117 | Sugiyama | HSPD1 HSP60 | LVQDVANNtNEEAGDGtttAtVLARSIAKEGFEKISKGANP |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P11047 | T856 | Sugiyama | LAMC1 LAMB2 | PNAVGNCNRLTGECLKCIyNtAGFyCDRCKDGFFGNPLAPN |
| P11142 | S544 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KYKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKIND |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P12277 | S164 | Sugiyama | CKB CKBB | PHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAEQ |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13667 | T238 | Sugiyama | PDIA4 ERP70 ERP72 | KAAKELSKRSPPIPLAKVDAtAETDLAKRFDVsGyPTLKIF |
| P13667 | T380 | Sugiyama | PDIA4 ERP70 ERP72 | PEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGHR |
| P14314 | T492 | Sugiyama | PRKCSH G19P1 | WQGPNRstTVRLLCGKEtMVtStTEPSRCEYLMELMTPAAC |
| P14550 | T78 | Sugiyama | AKR1A1 ALDR1 ALR | EALKEDVGPGKAVPREELFVtSKLWNTKHHPEDVEPALRKT |
| P14618 | T195 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | yVDDGLISLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAA |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S680 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDMLRR |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15880 | S281 | Sugiyama | RPS2 RPS4 | FtKsPyQEFtDHLVKtHtRVsVQRtQAPAVATt________ |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P15880 | T293 | Sugiyama | RPS2 RPS4 | LVKtHtRVsVQRtQAPAVATt____________________ |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17980 | T163 | Sugiyama | PSMC3 TBP1 | EKLKPGDLVGVNKDSyLILEtLPtEyDsRVKAMEVDERPtE |
| P18206 | S820 | Sugiyama | VCL | DAKAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEP |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18669 | T146 | Sugiyama | PGAM1 PGAMA CDABP0006 | MEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIARALPF |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P23284 | T81 | Sugiyama | PPIB CYPB | IFGLFGKTVPKTVDNFVALAtGEKGFGYKNSKFHRVIKDFM |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23921 | T555 | Sugiyama | RRM1 RR1 | IyyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTP |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26639 | T250 | Sugiyama | TARS1 TARS | FKYNKFKCRILNEKVNtPtttVyRCGPLIDLCRGPHVRHTG |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P31749 | T308 | SIGNOR | AKT1 PKB RAC | IKITDFGLCKEGIKDGAtMKtFCGtPEyLAPEVLEDNDyGR |
| P31946 | T228 | Sugiyama | YWHAB | LNEEsyKDstLIMQLLRDNLtLWtSENQGDEGDAGEGEN__ |
| P31947 | T228 | Sugiyama | SFN HME1 | LsEDsyKDstLIMQLLRDNLtLWTADNAGEEGGEAPQEPQs |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P33176 | T182 | Sugiyama | KIF5B KNS KNS1 | VPYVKGCTERFVCsPDEVMDtIDEGKSNRHVAVTNMNEHSS |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38117 | T172 | Sugiyama | ETFB FP585 | QVTLEGDKLKVEREIDGGLEtLRLKLPAVVTADLRLNEPRy |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39687 | T105 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | EKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCEV |
| P40227 | S49 | Sugiyama | CCT6A CCT6 CCTZ | GLQDVLRTNLGPKGTMKMLVsGAGDIKLTKDGNVLLHEMQI |
| P41236 | T55 | Sugiyama | PPP1R2 IPP2 | NVDEELSKKsQKWDEMNILAtyHPADKDyGLMKIDEPstPY |
| P43490 | T179 | Sugiyama | NAMPT PBEF PBEF1 | ITVATNSREQKKILAKyLLEtsGNLDGLEyKLHDFGyRGVS |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46937 | T379 | Sugiyama | YAP1 YAP65 | GGtQNPVssPGMsQELRTMttNssDPFLNsGtyHsRDEstD |
| P48444 | T329 | Sugiyama | ARCN1 COPD | KYGRIRLHVENEDKKGVQLQtHPNVDKKLFTAEsLIGLKNP |
| P48643 | T269 | Sugiyama | CCT5 CCTE KIAA0098 | AILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMI |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P50395 | T205 | Sugiyama | GDI2 RABGDIB | TGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsPYL |
| P50395 | T412 | Sugiyama | GDI2 RABGDIB | LGtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsEFDFE |
| P50990 | T286 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | MNFsKGEENLMDAQVKAIADtGANVVVtGGKVADMALHYAN |
| P50990 | T374 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | EVGDTQVVVFKHEKEDGAIstIVLRGstDNLMDDIERAVDD |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P53999 | S12 | Sugiyama | SUB1 PC4 RPO2TC1 | _________MPKSKELVsssssGsDsDsEVDKKLKRKKQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55060 | S342 | Sugiyama | CSE1L CAS XPO2 | ASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEAF |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60709 | S300 | Sugiyama | ACTB | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P61163 | T101 | Sugiyama | ACTR1A CTRN1 | KDWNDMERIWQYVYSKDQLQtFSEEHPVLLtEAPLNPRKNR |
| P61163 | T111 | Sugiyama | ACTR1A CTRN1 | QYVYSKDQLQtFSEEHPVLLtEAPLNPRKNRERAAEVFFET |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | T229 | Sugiyama | YWHAE | LsEEsyKDstLIMQLLRDNLtLWtsDMQGDGEEQNKEALQD |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62753 | T128 | Sugiyama | RPS6 OK/SW-cl.2 | VLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNLs |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T232 | Sugiyama | YWHAZ | KDstLIMQLLRDNLtLWtsDtQGDEAEAGEGGEN_______ |
| P63261 | S300 | Sugiyama | ACTG1 ACTG | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P67936 | T237 | Sugiyama | TPM4 | IDDLEEKLAQAKEENVGLHQtLDQtLNELNCI_________ |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P78371 | S144 | Sugiyama | CCT2 99D8.1 CCTB | QTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIAG |
| P78371 | T64 | Sugiyama | CCT2 99D8.1 CCTB | GPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVL |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q00839 | T530 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KTTWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtG |
| Q00839 | T532 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | TWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtGKL |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01518 | T165 | Sugiyama | CAP1 CAP | AMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVKA |
| Q01814 | S1242 | Sugiyama | ATP2B2 PMCA2 | DtsKSATSSsPGsPIHSLEtsL___________________ |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q12792 | S143 | Sugiyama | TWF1 PTK9 | GTVKEDVSLHGYKKyLLsQssPAPLtAAEEELRQIKINEVQ |
| Q13131 | T183 | SIGNOR|EPSD|PSP | PRKAA1 AMPK1 | NAKIADFGLsNMMsDGEFLRtsCGsPNyAAPEVISGRLYAG |
| Q13136 | T572 | Sugiyama | PPFIA1 LIP1 | LRRPQKGRLAALRDEPSKVQtLNEQDWERAQQASVLANVAQ |
| Q13153 | T109 | Sugiyama | PAK1 | FDAVTGEFTGMPEQWARLLQtsNITKsEQKKNPQAVLDVLE |
| Q13177 | T108 | Sugiyama | PAK2 | FDAVTGEFTGMPEQWARLLQtsNItKLEQKKNPQAVLDVLK |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13561 | T315 | Sugiyama | DCTN2 DCTN50 | KHKASVEDADTQSKVHQLyEtIQRWsPIASTLPELVQRLVT |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14012 | T177 | GPS6|SIGNOR|EPSD|PSP | CAMK1 | KIMISDFGLSKMEDPGSVLstACGTPGYVAPEVLAQKPYSK |
| Q14257 | S298 | Sugiyama | RCN2 ERC55 | NGDKKLsEEEILENPDLFLtsEAtDyGRQLHDDyFyHDEL_ |
| Q14444 | T303 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | YTEQSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEV |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | T109 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LTIVDTGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| Q14677 | T270 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | FKDEEETVTTKHIHItQATEttttRHKRTANPsKtIDLGAA |
| Q14980 | T1166 | Sugiyama | NUMA1 NMP22 NUMA | LERsLEAERASRAERDsALEtLQGQLEEKAQELGHsQsALA |
| Q15084 | S230 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | QTKGKVKLAAVDAtVNQVLAsRYGIRGFPtIKIFQKGEsPV |
| Q15084 | T166 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | YSSGKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFY |
| Q15084 | T223 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AAsEVKEQTKGKVKLAAVDAtVNQVLAsRYGIRGFPtIKIF |
| Q15293 | T100 | Sugiyama | RCN1 RCN | sKERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNV |
| Q15293 | T211 | Sugiyama | RCN1 RCN | FTAFLHPEEFEHMKEIVVLEtLEDIDKNGDGFVDQDEyIAD |
| Q15427 | T14 | Sugiyama | SF3B4 SAP49 | _______MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFL |
| Q16566 | S12 | EPSD|PSP | CAMK4 CAMK CAMK-GR CAMKIV | _________MLKVTVPSCSAssCSSVTASAAPGTASLVPDY |
| Q16566 | S13 | EPSD|PSP | CAMK4 CAMK CAMK-GR CAMKIV | ________MLKVTVPSCSAssCSSVTASAAPGTASLVPDYW |
| Q16566 | T200 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | CAMK4 CAMK CAMK-GR CAMKIV | PLKIADFGLsKIVEHQVLMKtVCGTPGYCAPEILRGCAYGP |
| Q16576 | T10 | Sugiyama | RBBP7 RBAP46 | ___________MAsKEMFEDtVEERVINEEYKIWKKNTPFL |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF7 | S408 | Sugiyama | HSP90AB3P HSP90BC | EPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| Q58FF8 | S308 | Sugiyama | HSP90AB2P HSP90BB | YMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKRMEE |
| Q58FF8 | T104 | Sugiyama | HSP90AB2P HSP90BB | LTLVDTGIGMTKADLINNLGtIAKFQDQTEYLEEMQVKEVV |
| Q5SW79 | S552 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | yNRPVINEKHKDLIKDWALssAAAVMEERKPLTTSGFHHsE |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6FI81 | S305 | Sugiyama | CIAPIN1 CUA001 PRO0915 | CAsCPyLGMPAFKPGEKVLLsDsNLHDA_____________ |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q8IU85 | T180 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CAMK1D CAMKID | KIMISDFGLSKMEGKGDVMstACGtPGYVAPEVLAQKPYSK |
| Q8IV50 | T210 | Sugiyama | LYSMD2 | STQAAKKLKEESRDEEsPyAtSLyHs_______________ |
| Q8N1G4 | T27 | Sugiyama | LRRC47 KIAA1185 | SESWPELELAERERRRELLLtGPGLEERVRAAGGQLPPRLF |
| Q8N5S9 | S111 | Sugiyama | CAMKK1 CAMKKA | yAtGPAsHIsPRAWRRPtIEsHHVAIsDAEDCVQLNQYKLQ |
| Q8N5S9 | S117 | Sugiyama | CAMKK1 CAMKKA | sHIsPRAWRRPtIEsHHVAIsDAEDCVQLNQYKLQSEIGKG |
| Q8N5S9 | S149 | Sugiyama | CAMKK1 CAMKKA | KLQSEIGKGAYGVVRLAYNEsEDRHYAMKVLSKKKLLKQYG |
| Q8N5S9 | S179 | Sugiyama | CAMKK1 CAMKKA | LSKKKLLKQYGFPRRPPPRGsQAAQGGPAKQLLPLERVYQE |
| Q8N5S9 | S475 | Sugiyama | CAMKK1 CAMKKA | RKRsFGNPFEPQARREERSMsAPGNLLVKEGFGEGGKsPEL |
| Q8N5S9 | S492 | Sugiyama | CAMKK1 CAMKKA | RSMsAPGNLLVKEGFGEGGKsPELPGVQEDEAAS_______ |
| Q8N5S9 | S52 | Sugiyama | CAMKK1 CAMKKA | DGGPEPTRNGVDPPPRARAAsVIPGstSRLLPARPsLsARK |
| Q8N5S9 | S57 | Sugiyama | CAMKK1 CAMKKA | PTRNGVDPPPRARAAsVIPGstSRLLPARPsLsARKLsLQE |
| Q8N5S9 | S67 | Sugiyama | CAMKK1 CAMKKA | RARAAsVIPGstSRLLPARPsLsARKLsLQERPAGsyLEAQ |
| Q8N5S9 | S69 | Sugiyama | CAMKK1 CAMKKA | RAAsVIPGstSRLLPARPsLsARKLsLQERPAGsyLEAQAG |
| Q8N5S9 | S82 | Sugiyama | CAMKK1 CAMKKA | LPARPsLsARKLsLQERPAGsyLEAQAGPyAtGPAsHIsPR |
| Q8N5S9 | S97 | Sugiyama | CAMKK1 CAMKKA | ERPAGsyLEAQAGPyAtGPAsHIsPRAWRRPtIEsHHVAIs |
| Q8N5S9 | T108 | Sugiyama | CAMKK1 CAMKKA | AGPyAtGPAsHIsPRAWRRPtIEsHHVAIsDAEDCVQLNQY |
| Q8N5S9 | T26 | Sugiyama | CAMKK1 CAMKKA | AVCCQDPRAELVERVAAIDVtHLEEADGGPEPTRNGVDPPP |
| Q8N5S9 | T430 | Sugiyama | CAMKK1 CAMKKA | TKNGEEPLPSEEEHCSVVEVtEEEVKNSVRLIPSWTTVILV |
| Q8N5S9 | T58 | Sugiyama | CAMKK1 CAMKKA | TRNGVDPPPRARAAsVIPGstSRLLPARPsLsARKLsLQER |
| Q8N5S9 | T93 | Sugiyama | CAMKK1 CAMKKA | LsLQERPAGsyLEAQAGPyAtGPAsHIsPRAWRRPtIEsHH |
| Q8N5S9 | Y91 | Sugiyama | CAMKK1 CAMKKA | RKLsLQERPAGsyLEAQAGPyAtGPAsHIsPRAWRRPtIEs |
| Q8NBJ5 | S616 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | EQQALSREAKNsDVLQsPLDsAARDEL______________ |
| Q8NBJ7 | T260 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | SPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPD |
| Q8NBJ7 | T42 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | LGNGQATSMVQLQGGRFLMGtNsPDSRDGDGPVREATVKPF |
| Q8NBS9 | T122 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | LGDKYNSMEDAKVYVAKVDCtAHsDVCsAQGVRGYPTLKLF |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TEQ6 | T853 | Sugiyama | GEMIN5 | KEKPETLIKKRKARsLLPLstsLDHRSKEELHQDCLVLATA |
| Q8WU90 | T348 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | sVNDIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLs |
| Q99497 | T154 | Sugiyama | PARK7 | MNGGHytysENRVEKDGLILtSRGPGTSFEFALAIVEALNG |
| Q99613 | S39 | Sugiyama | EIF3C EIF3S8 | GEELVTKPVGGNyGKQPLLLsEDEEDTKRVVRSAKDKRFEE |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99832 | T351 | Sugiyama | CCT7 CCTH NIP7-1 | QtSVNALSADVLGRCQVFEEtQIGGERyNFFtGCPKAKTCt |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BUJ2 | T113 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | SGPDGHYAMDNITRQNQFyDtQVIKQENESGyERRPLEMEQ |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BZI7 | S166 | Sugiyama | UPF3B RENT3B UPF3X | KRDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIE |
| Q9HAP6 | S120 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | DEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGDQL |
| Q9NS87 | T1158 | Sugiyama | KIF15 KLP2 KNSL7 | DPQsPKtPPHFQTHLAKLLEtQEQEIEDGRAsKTsLEHLVT |
| Q9NUP9 | S120 | Sugiyama | LIN7C MALS3 VELI3 | EEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGDQL |
| Q9NUQ3 | T102 | Sugiyama | TXLNG CXorf15 ELRG LSR5 | EDEGsDFItENRNLVsPAyCtQEsREEIPGGEARTDPPDGQ |
| Q9UBQ5 | T28 | Sugiyama | EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001 | RANVGKLLKGIDRyNPENLAtLERYVETQAKENAyDLEANL |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UNF1 | T92 | Sugiyama | MAGED2 BCG1 | tPEAREAPAtQAssttQLtDtQVLAAENKSLAADTKKQNAD |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9UQN3 | T124 | Sugiyama | CHMP2B CGI-84 | TTAKTMQAVNKKMDPQKTLQtMQNFQKENMKMEMTEEMIND |
| Q9Y2B0 | T79 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGEQIDPs |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular Senescence | R-HSA-2559583 | 0.000012 | 4.932 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 0.000022 | 4.661 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 0.000023 | 4.645 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 0.000031 | 4.503 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 0.000031 | 4.503 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 0.000035 | 4.462 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 0.000065 | 4.190 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 0.000069 | 4.159 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 0.000064 | 4.195 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 0.000057 | 4.244 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 0.000101 | 3.997 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 0.000121 | 3.919 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 0.000129 | 3.888 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 0.000219 | 3.659 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 0.000252 | 3.598 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 0.000370 | 3.432 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 0.000464 | 3.334 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 0.000464 | 3.334 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 0.000560 | 3.252 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 0.000733 | 3.135 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 0.000733 | 3.135 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 0.000733 | 3.135 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 0.000733 | 3.135 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 0.001057 | 2.976 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 0.001057 | 2.976 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 0.000983 | 3.008 | 0 | 0 |
| M Phase | R-HSA-68886 | 0.001075 | 2.968 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 0.001343 | 2.872 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 0.001343 | 2.872 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 0.001281 | 2.892 | 1 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 0.001496 | 2.825 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 0.001496 | 2.825 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 0.001422 | 2.847 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 0.001511 | 2.821 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 0.001643 | 2.784 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 0.001702 | 2.769 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 0.001702 | 2.769 | 1 | 0 |
| Muscle contraction | R-HSA-397014 | 0.001668 | 2.778 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 0.001919 | 2.717 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 0.002122 | 2.673 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 0.002038 | 2.691 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 0.002141 | 2.669 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 0.002663 | 2.575 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 0.002446 | 2.612 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 0.002446 | 2.612 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 0.002727 | 2.564 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 0.002663 | 2.575 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 0.002727 | 2.564 | 1 | 1 |
| Cellular responses to stress | R-HSA-2262752 | 0.002511 | 2.600 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 0.002905 | 2.537 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 0.003317 | 2.479 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 0.003583 | 2.446 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 0.003623 | 2.441 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 0.003761 | 2.425 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 0.004106 | 2.387 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 0.004516 | 2.345 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 0.005188 | 2.285 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 0.005651 | 2.248 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 0.005455 | 2.263 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 0.005882 | 2.230 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 0.005992 | 2.222 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 0.007316 | 2.136 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 0.006962 | 2.157 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 0.007499 | 2.125 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 0.008134 | 2.090 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 0.008498 | 2.071 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 0.008674 | 2.062 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 0.009296 | 2.032 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 0.009951 | 2.002 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 0.010089 | 1.996 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 0.010154 | 1.993 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 0.010154 | 1.993 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 0.010836 | 1.965 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 0.013532 | 1.869 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 0.013532 | 1.869 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 0.013532 | 1.869 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 0.013532 | 1.869 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 0.013532 | 1.869 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 0.012054 | 1.919 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 0.013654 | 1.865 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 0.013885 | 1.857 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 0.013885 | 1.857 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 0.012847 | 1.891 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 0.013956 | 1.855 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 0.014168 | 1.849 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 0.014168 | 1.849 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 0.016158 | 1.792 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 0.016158 | 1.792 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 0.015722 | 1.804 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 0.017469 | 1.758 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 0.019064 | 1.720 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 0.019064 | 1.720 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 0.018983 | 1.722 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 0.018915 | 1.723 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 0.019685 | 1.706 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 0.019903 | 1.701 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 0.019961 | 1.700 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 0.021802 | 1.662 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 0.021802 | 1.662 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 0.021802 | 1.662 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 0.021802 | 1.662 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 0.021859 | 1.660 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 0.021891 | 1.660 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 0.024049 | 1.619 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 0.024049 | 1.619 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 0.023603 | 1.627 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 0.022292 | 1.652 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 0.024086 | 1.618 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 0.024251 | 1.615 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 0.024251 | 1.615 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 0.025252 | 1.598 | 1 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 0.028166 | 1.550 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 0.028762 | 1.541 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 0.028706 | 1.542 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 0.028706 | 1.542 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 0.026269 | 1.581 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 0.026770 | 1.572 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 0.028762 | 1.541 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 0.028002 | 1.553 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 0.029449 | 1.531 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 0.029449 | 1.531 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 0.029449 | 1.531 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 0.031684 | 1.499 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 0.031793 | 1.498 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 0.033761 | 1.472 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 0.033761 | 1.472 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 0.038056 | 1.420 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 0.035449 | 1.450 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 0.037401 | 1.427 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 0.035449 | 1.450 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 0.034946 | 1.457 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 0.037335 | 1.428 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 0.038056 | 1.420 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 0.035449 | 1.450 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 0.038184 | 1.418 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 0.038475 | 1.415 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 0.038567 | 1.414 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 0.038567 | 1.414 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 0.039245 | 1.406 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 0.039461 | 1.404 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 0.040725 | 1.390 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 0.040725 | 1.390 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 0.041598 | 1.381 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 0.041820 | 1.379 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 0.041820 | 1.379 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 0.042659 | 1.370 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 0.042659 | 1.370 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 0.042659 | 1.370 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 0.042659 | 1.370 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 0.043644 | 1.360 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 0.043722 | 1.359 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 0.043722 | 1.359 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 0.048230 | 1.317 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 0.043722 | 1.359 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 0.048325 | 1.316 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 0.048325 | 1.316 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 0.048325 | 1.316 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 0.048325 | 1.316 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 0.051473 | 1.288 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 0.051473 | 1.288 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 0.051473 | 1.288 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 0.051473 | 1.288 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 0.051473 | 1.288 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 0.058197 | 1.235 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 0.057987 | 1.237 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 0.053170 | 1.274 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 0.060169 | 1.221 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 0.054370 | 1.265 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 0.059687 | 1.224 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 0.059467 | 1.226 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 0.053170 | 1.274 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 0.052699 | 1.278 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 0.052038 | 1.284 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 0.058197 | 1.235 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 0.057166 | 1.243 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 0.058197 | 1.235 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 0.057987 | 1.237 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 0.057427 | 1.241 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 0.060169 | 1.221 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 0.052877 | 1.277 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 0.060588 | 1.218 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 0.060588 | 1.218 | 0 | 0 |
| S Phase | R-HSA-69242 | 0.063771 | 1.195 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 0.063864 | 1.195 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 0.064665 | 1.189 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 0.064665 | 1.189 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 0.067636 | 1.170 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 0.067690 | 1.169 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 0.068716 | 1.163 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 0.069902 | 1.156 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 0.083501 | 1.078 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 0.083501 | 1.078 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 0.083501 | 1.078 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 0.083501 | 1.078 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 0.083501 | 1.078 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 0.071392 | 1.146 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 0.079580 | 1.099 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 0.074437 | 1.128 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 0.071392 | 1.146 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 0.084011 | 1.076 | 1 | 1 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 0.075400 | 1.123 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 0.072804 | 1.138 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 0.083501 | 1.078 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 0.071392 | 1.146 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 0.084011 | 1.076 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 0.080662 | 1.093 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 0.080392 | 1.095 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 0.070020 | 1.155 | 1 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 0.072804 | 1.138 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 0.071157 | 1.148 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 0.070020 | 1.155 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 0.083970 | 1.076 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 0.084011 | 1.076 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 0.074731 | 1.126 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 0.074731 | 1.126 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 0.084294 | 1.074 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 0.085362 | 1.069 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 0.085970 | 1.066 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 0.122603 | 0.912 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 0.122603 | 0.912 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 0.122603 | 0.912 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 0.122603 | 0.912 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 0.122603 | 0.912 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 0.122603 | 0.912 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 0.122603 | 0.912 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 0.160038 | 0.796 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 0.160038 | 0.796 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 0.195879 | 0.708 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 0.195879 | 0.708 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 0.195879 | 0.708 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 0.097243 | 1.012 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 0.230193 | 0.638 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 0.230193 | 0.638 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 0.230193 | 0.638 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 0.230193 | 0.638 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 0.230193 | 0.638 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 0.230193 | 0.638 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 0.230193 | 0.638 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 0.111015 | 0.955 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 0.111015 | 0.955 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 0.111015 | 0.955 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 0.125255 | 0.902 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 0.263044 | 0.580 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 0.263044 | 0.580 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 0.263044 | 0.580 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 0.139900 | 0.854 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 0.139900 | 0.854 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 0.139900 | 0.854 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 0.139900 | 0.854 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 0.088868 | 1.051 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 0.154888 | 0.810 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 0.154888 | 0.810 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 0.154888 | 0.810 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 0.154888 | 0.810 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 0.154888 | 0.810 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 0.294495 | 0.531 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 0.294495 | 0.531 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 0.294495 | 0.531 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 0.294495 | 0.531 | 0 | 0 |
| Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS) | R-HSA-5619063 | 0.294495 | 0.531 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 0.170163 | 0.769 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 0.170163 | 0.769 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 0.106267 | 0.974 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 0.115426 | 0.938 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 0.185675 | 0.731 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 0.324606 | 0.489 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 0.324606 | 0.489 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 0.124871 | 0.904 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 0.201375 | 0.696 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 0.201375 | 0.696 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 0.217219 | 0.663 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 0.353433 | 0.452 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 0.353433 | 0.452 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 0.353433 | 0.452 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 0.353433 | 0.452 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 0.353433 | 0.452 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 0.353433 | 0.452 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 0.095236 | 1.021 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 0.249180 | 0.603 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 0.381032 | 0.419 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 0.381032 | 0.419 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 0.143584 | 0.843 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 0.265224 | 0.576 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 0.197527 | 0.704 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 0.124432 | 0.905 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 0.208640 | 0.681 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 0.281268 | 0.551 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 0.407454 | 0.390 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 0.407454 | 0.390 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 0.407454 | 0.390 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 0.130717 | 0.884 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 0.297281 | 0.527 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 0.297281 | 0.527 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 0.297281 | 0.527 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 0.297281 | 0.527 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 0.297281 | 0.527 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 0.297281 | 0.527 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 0.432750 | 0.364 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 0.211515 | 0.675 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 0.178429 | 0.749 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 0.178429 | 0.749 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 0.178429 | 0.749 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 0.178429 | 0.749 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 0.178429 | 0.749 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 0.289371 | 0.539 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 0.223709 | 0.650 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 0.267253 | 0.573 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 0.276804 | 0.558 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 0.391403 | 0.407 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 0.322150 | 0.492 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 0.374133 | 0.427 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 0.374133 | 0.427 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 0.150060 | 0.824 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 0.312905 | 0.505 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 0.327781 | 0.484 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 0.387396 | 0.412 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 0.189359 | 0.723 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 0.430805 | 0.366 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 0.166138 | 0.780 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 0.171244 | 0.766 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 0.325220 | 0.488 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 0.305271 | 0.515 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 0.165155 | 0.782 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 0.106455 | 0.973 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 0.231574 | 0.635 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 0.297281 | 0.527 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 0.294495 | 0.531 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 0.170163 | 0.769 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 0.432750 | 0.364 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 0.432750 | 0.364 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 0.193128 | 0.714 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 0.371918 | 0.430 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 0.132748 | 0.877 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 0.233167 | 0.632 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 0.325220 | 0.488 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 0.124871 | 0.904 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 0.092980 | 1.032 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 0.186564 | 0.729 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 0.265224 | 0.576 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 0.432750 | 0.364 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 0.289371 | 0.539 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 0.189996 | 0.721 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 0.301152 | 0.521 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 0.265926 | 0.575 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 0.201910 | 0.695 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 0.249634 | 0.603 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 0.097243 | 1.012 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 0.294495 | 0.531 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 0.170163 | 0.769 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 0.281268 | 0.551 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 0.407454 | 0.390 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 0.391403 | 0.407 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 0.391403 | 0.407 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 0.101158 | 0.995 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 0.165155 | 0.782 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 0.097243 | 1.012 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 0.324606 | 0.489 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 0.353433 | 0.452 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 0.353433 | 0.452 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 0.175768 | 0.755 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 0.381032 | 0.419 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 0.242728 | 0.615 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 0.242728 | 0.615 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 0.373255 | 0.428 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 0.278598 | 0.555 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 0.172468 | 0.763 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 0.222464 | 0.653 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 0.395282 | 0.403 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 0.395282 | 0.403 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 0.337418 | 0.472 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 0.086574 | 1.063 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 0.157226 | 0.803 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 0.381796 | 0.418 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 0.170163 | 0.769 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 0.208640 | 0.681 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 0.295119 | 0.530 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 0.313498 | 0.504 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 0.294495 | 0.531 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 0.407454 | 0.390 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 0.280223 | 0.552 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 0.415777 | 0.381 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 0.406879 | 0.391 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 0.202559 | 0.693 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 0.348388 | 0.458 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 0.367686 | 0.435 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 0.319861 | 0.495 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 0.092980 | 1.032 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 0.154888 | 0.810 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 0.315479 | 0.501 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 0.245293 | 0.610 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 0.208640 | 0.681 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 0.217219 | 0.663 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 0.140249 | 0.853 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 0.295847 | 0.529 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 0.122603 | 0.912 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 0.160038 | 0.796 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 0.230193 | 0.638 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 0.125255 | 0.902 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 0.263044 | 0.580 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 0.294495 | 0.531 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 0.294495 | 0.531 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 0.294495 | 0.531 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 0.170163 | 0.769 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 0.201375 | 0.696 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 0.092980 | 1.032 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 0.154742 | 0.810 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 0.233167 | 0.632 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 0.165155 | 0.782 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 0.381032 | 0.419 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 0.381032 | 0.419 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 0.186564 | 0.729 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 0.265224 | 0.576 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 0.265224 | 0.576 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 0.432750 | 0.364 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 0.329115 | 0.483 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 0.265926 | 0.575 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 0.286410 | 0.543 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 0.288530 | 0.540 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 0.415874 | 0.381 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 0.092980 | 1.032 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 0.280223 | 0.552 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 0.118280 | 0.927 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 0.381032 | 0.419 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 0.124568 | 0.905 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 0.255614 | 0.592 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 0.277624 | 0.557 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 0.135968 | 0.867 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 0.113484 | 0.945 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 0.175768 | 0.755 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 0.193128 | 0.714 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 0.189359 | 0.723 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 0.265224 | 0.576 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 0.354566 | 0.450 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 0.282113 | 0.550 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 0.117393 | 0.930 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 0.154888 | 0.810 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 0.154888 | 0.810 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 0.154888 | 0.810 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 0.201375 | 0.696 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 0.249180 | 0.603 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 0.106455 | 0.973 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 0.407454 | 0.390 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 0.407454 | 0.390 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 0.407454 | 0.390 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 0.432750 | 0.364 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 0.432750 | 0.364 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 0.329115 | 0.483 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 0.344889 | 0.462 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 0.344889 | 0.462 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 0.312956 | 0.505 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 0.207972 | 0.682 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 0.364353 | 0.438 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 0.120726 | 0.918 | 1 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 0.400922 | 0.397 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 0.157226 | 0.803 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 0.329115 | 0.483 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 0.120662 | 0.918 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 0.120726 | 0.918 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 0.120726 | 0.918 | 1 | 0 |
| PLC beta mediated events | R-HSA-112043 | 0.185725 | 0.731 | 1 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 0.255614 | 0.592 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 0.386390 | 0.413 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 0.237696 | 0.624 | 1 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 0.229744 | 0.639 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 0.113484 | 0.945 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 0.093367 | 1.030 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 0.211515 | 0.675 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 0.258366 | 0.588 | 0 | 0 |
| Kinesins | R-HSA-983189 | 0.344779 | 0.462 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 0.176501 | 0.753 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 0.406582 | 0.391 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 0.395282 | 0.403 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 0.383900 | 0.416 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 0.319088 | 0.496 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 0.193128 | 0.714 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 0.172468 | 0.763 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 0.142399 | 0.846 | 1 | 0 |
| G1/S Transition | R-HSA-69206 | 0.269798 | 0.569 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 0.151566 | 0.819 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 0.122603 | 0.912 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 0.263044 | 0.580 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 0.154888 | 0.810 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 0.294495 | 0.531 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 0.233167 | 0.632 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 0.233167 | 0.632 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 0.381032 | 0.419 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 0.381032 | 0.419 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 0.143584 | 0.843 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 0.265224 | 0.576 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 0.407454 | 0.390 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 0.242728 | 0.615 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 0.313239 | 0.504 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 0.178429 | 0.749 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 0.376050 | 0.425 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 0.324771 | 0.488 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 0.336585 | 0.473 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 0.102867 | 0.988 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 0.140572 | 0.852 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 0.139177 | 0.856 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 0.139177 | 0.856 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 0.202559 | 0.693 | 1 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 0.356177 | 0.448 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 0.290013 | 0.538 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 0.306286 | 0.514 | 1 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 0.393650 | 0.405 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 0.236523 | 0.626 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 0.274185 | 0.562 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 0.406879 | 0.391 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 0.154888 | 0.810 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 0.170163 | 0.769 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 0.313239 | 0.504 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 0.427026 | 0.370 | 1 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 0.251165 | 0.600 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 0.231574 | 0.635 | 1 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 0.125255 | 0.902 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 0.115426 | 0.938 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 0.151556 | 0.819 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 0.151556 | 0.819 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 0.407454 | 0.390 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 0.432750 | 0.364 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 0.277624 | 0.557 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 0.305754 | 0.515 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 0.422733 | 0.374 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 0.321158 | 0.493 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 0.265224 | 0.576 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 0.348388 | 0.458 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 0.406582 | 0.391 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 0.395282 | 0.403 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 0.413493 | 0.384 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 0.324771 | 0.488 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 0.092980 | 1.032 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 0.125255 | 0.902 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 0.263044 | 0.580 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 0.263044 | 0.580 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 0.139900 | 0.854 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 0.201375 | 0.696 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 0.134583 | 0.871 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 0.233167 | 0.632 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 0.381032 | 0.419 | 0 | 0 |
| Calcitonin-like ligand receptors | R-HSA-419812 | 0.381032 | 0.419 | 0 | 0 |
| RSK activation | R-HSA-444257 | 0.381032 | 0.419 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 0.407454 | 0.390 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 0.407454 | 0.390 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 0.313239 | 0.504 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 0.432750 | 0.364 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 0.329115 | 0.483 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 0.257764 | 0.589 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 0.376050 | 0.425 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 0.376050 | 0.425 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 0.391403 | 0.407 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 0.406582 | 0.391 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 0.421577 | 0.375 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 0.374133 | 0.427 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 0.375192 | 0.426 | 0 | 0 |
| Immune System | R-HSA-168256 | 0.281120 | 0.551 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 0.383900 | 0.416 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 0.424709 | 0.372 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 0.305754 | 0.515 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 0.313239 | 0.504 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 0.391403 | 0.407 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 0.305754 | 0.515 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 0.391403 | 0.407 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 0.407374 | 0.390 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 0.395282 | 0.403 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 0.407454 | 0.390 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 0.329115 | 0.483 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 0.193128 | 0.714 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 0.344889 | 0.462 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 0.391403 | 0.407 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 0.422699 | 0.374 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 0.100767 | 0.997 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 0.347648 | 0.459 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 0.214102 | 0.669 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 0.139900 | 0.854 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 0.208640 | 0.681 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 0.344779 | 0.462 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 0.234248 | 0.630 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 0.397556 | 0.401 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 0.151924 | 0.818 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 0.418410 | 0.378 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 0.160038 | 0.796 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 0.097243 | 1.012 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 0.263044 | 0.580 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 0.154888 | 0.810 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 0.294495 | 0.531 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 0.294495 | 0.531 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 0.201375 | 0.696 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 0.407454 | 0.390 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 0.297281 | 0.527 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 0.313239 | 0.504 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 0.086743 | 1.062 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 0.322150 | 0.492 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 0.360540 | 0.443 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 0.398053 | 0.400 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 0.317138 | 0.499 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 0.324606 | 0.489 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 0.135783 | 0.867 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 0.313239 | 0.504 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 0.281268 | 0.551 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 0.208234 | 0.681 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 0.376050 | 0.425 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 0.431392 | 0.365 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 0.130216 | 0.885 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 0.111015 | 0.955 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 0.407454 | 0.390 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 0.407454 | 0.390 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 0.432750 | 0.364 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 0.145703 | 0.837 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 0.129055 | 0.889 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 0.121958 | 0.914 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 0.376050 | 0.425 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 0.347176 | 0.459 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 0.125255 | 0.902 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 0.263044 | 0.580 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 0.154888 | 0.810 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 0.353433 | 0.452 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 0.233167 | 0.632 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 0.165155 | 0.782 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 0.265224 | 0.576 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 0.360540 | 0.443 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 0.178429 | 0.749 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 0.193128 | 0.714 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 0.154888 | 0.810 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 0.154888 | 0.810 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 0.353433 | 0.452 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 0.339131 | 0.470 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 0.383625 | 0.416 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 0.244581 | 0.612 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 0.301332 | 0.521 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 0.406582 | 0.391 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 0.406879 | 0.391 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 0.170163 | 0.769 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 0.106267 | 0.974 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 0.249180 | 0.603 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 0.249180 | 0.603 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 0.281268 | 0.551 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 0.170163 | 0.769 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 0.406582 | 0.391 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 0.125255 | 0.902 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 0.406582 | 0.391 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 0.424709 | 0.372 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 0.395282 | 0.403 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 0.233625 | 0.631 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 0.313239 | 0.504 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 0.313239 | 0.504 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 0.102944 | 0.987 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 0.305754 | 0.515 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 0.313239 | 0.504 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 0.171244 | 0.766 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 0.406582 | 0.391 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 0.265224 | 0.576 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 0.281268 | 0.551 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 0.344889 | 0.462 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 0.324771 | 0.488 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 0.185675 | 0.731 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 0.150749 | 0.822 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 0.164015 | 0.785 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 0.329115 | 0.483 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 0.421577 | 0.375 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 0.421577 | 0.375 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 0.389249 | 0.410 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 0.432810 | 0.364 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 0.436374 | 0.360 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 0.436374 | 0.360 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 0.436374 | 0.360 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 0.436374 | 0.360 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 0.441239 | 0.355 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 0.441240 | 0.355 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 0.441240 | 0.355 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 0.441934 | 0.355 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 0.443185 | 0.353 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 0.446493 | 0.350 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 0.449640 | 0.347 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 0.450963 | 0.346 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 0.450963 | 0.346 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 0.450963 | 0.346 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 0.450963 | 0.346 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 0.451464 | 0.345 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 0.451464 | 0.345 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 0.451464 | 0.345 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 0.455123 | 0.342 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 0.456968 | 0.340 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 0.456968 | 0.340 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 0.456968 | 0.340 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 0.456968 | 0.340 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 0.456968 | 0.340 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 0.456968 | 0.340 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 0.456968 | 0.340 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 0.456968 | 0.340 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 0.456968 | 0.340 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 0.456968 | 0.340 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 0.459295 | 0.338 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 0.462615 | 0.335 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 0.465331 | 0.332 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 0.465335 | 0.332 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 0.465335 | 0.332 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 0.465335 | 0.332 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 0.465335 | 0.332 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 0.465335 | 0.332 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 0.465335 | 0.332 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 0.465335 | 0.332 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 0.470360 | 0.328 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 0.470360 | 0.328 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 0.479482 | 0.319 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 0.479482 | 0.319 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 0.479482 | 0.319 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 0.479718 | 0.319 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 0.479718 | 0.319 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 0.480153 | 0.319 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 0.480153 | 0.319 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 0.480153 | 0.319 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 0.480153 | 0.319 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 0.480153 | 0.319 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 0.480153 | 0.319 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 0.480153 | 0.319 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 0.480153 | 0.319 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 0.484783 | 0.314 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 0.485148 | 0.314 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 0.485782 | 0.314 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 0.489011 | 0.311 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 0.489011 | 0.311 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 0.489011 | 0.311 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 0.491083 | 0.309 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 0.491083 | 0.309 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 0.493397 | 0.307 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 0.496652 | 0.304 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 0.498236 | 0.303 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 0.501793 | 0.299 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 0.502349 | 0.299 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 0.502349 | 0.299 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 0.502349 | 0.299 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 0.502349 | 0.299 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 0.502349 | 0.299 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 0.502349 | 0.299 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 0.502349 | 0.299 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 0.502349 | 0.299 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 0.507074 | 0.295 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 0.507074 | 0.295 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 0.507074 | 0.295 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 0.507074 | 0.295 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 0.507074 | 0.295 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 0.507074 | 0.295 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 0.514637 | 0.288 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 0.518037 | 0.286 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 0.518037 | 0.286 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 0.520508 | 0.284 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 0.520508 | 0.284 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 0.520508 | 0.284 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 0.520508 | 0.284 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 0.520508 | 0.284 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 0.523599 | 0.281 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 0.523599 | 0.281 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 0.523599 | 0.281 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 0.523599 | 0.281 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 0.523599 | 0.281 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 0.523599 | 0.281 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 0.523599 | 0.281 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 0.523599 | 0.281 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 0.523599 | 0.281 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 0.525462 | 0.279 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 0.528545 | 0.277 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 0.528545 | 0.277 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 0.528545 | 0.277 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 0.533695 | 0.273 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 0.533695 | 0.273 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 0.533695 | 0.273 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 0.533695 | 0.273 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 0.533695 | 0.273 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 0.533695 | 0.273 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 0.534120 | 0.272 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 0.534379 | 0.272 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 0.534379 | 0.272 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 0.534379 | 0.272 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 0.539057 | 0.268 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 0.543211 | 0.265 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 0.543943 | 0.264 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 0.543943 | 0.264 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 0.543943 | 0.264 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 0.543943 | 0.264 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 0.543943 | 0.264 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 0.543943 | 0.264 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 0.543943 | 0.264 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 0.543943 | 0.264 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 0.546631 | 0.262 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 0.546631 | 0.262 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 0.546631 | 0.262 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 0.547037 | 0.262 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 0.555252 | 0.256 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 0.557591 | 0.254 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 0.559280 | 0.252 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 0.559280 | 0.252 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 0.559314 | 0.252 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 0.559314 | 0.252 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 0.559314 | 0.252 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 0.562482 | 0.250 | 1 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 0.563419 | 0.249 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 0.563419 | 0.249 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 0.563419 | 0.249 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 0.563419 | 0.249 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 0.563419 | 0.249 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 0.563419 | 0.249 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 0.563419 | 0.249 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 0.563419 | 0.249 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 0.563419 | 0.249 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 0.565843 | 0.247 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 0.569178 | 0.245 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 0.569253 | 0.245 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 0.571513 | 0.243 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 0.571513 | 0.243 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 0.571513 | 0.243 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 0.571741 | 0.243 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 0.571741 | 0.243 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 0.571741 | 0.243 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 0.580641 | 0.236 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 0.582065 | 0.235 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 0.582065 | 0.235 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 0.582065 | 0.235 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 0.582065 | 0.235 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 0.582065 | 0.235 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 0.582065 | 0.235 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 0.583912 | 0.234 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 0.583912 | 0.234 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 0.585139 | 0.233 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 0.585217 | 0.233 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 0.585845 | 0.232 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 0.586025 | 0.232 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 0.586809 | 0.232 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 0.588776 | 0.230 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 0.588776 | 0.230 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 0.588776 | 0.230 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 0.592549 | 0.227 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 0.592549 | 0.227 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 0.594304 | 0.226 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 0.595826 | 0.225 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 0.595826 | 0.225 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 0.595826 | 0.225 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 0.595826 | 0.225 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 0.595826 | 0.225 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 0.596706 | 0.224 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 0.598330 | 0.223 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 0.599886 | 0.222 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 0.599886 | 0.222 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 0.599915 | 0.222 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 0.599915 | 0.222 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 0.599915 | 0.222 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 0.599915 | 0.222 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 0.599915 | 0.222 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 0.599915 | 0.222 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 0.599915 | 0.222 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 0.602500 | 0.220 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 0.604272 | 0.219 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 0.607482 | 0.216 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 0.607482 | 0.216 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 0.607482 | 0.216 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 0.607482 | 0.216 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 0.607482 | 0.216 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 0.607482 | 0.216 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 0.610009 | 0.215 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 0.610562 | 0.214 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 0.610562 | 0.214 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 0.610618 | 0.214 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 0.614332 | 0.212 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 0.616687 | 0.210 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 0.617004 | 0.210 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 0.617004 | 0.210 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 0.617004 | 0.210 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 0.617004 | 0.210 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 0.617004 | 0.210 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 0.618881 | 0.208 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 0.618881 | 0.208 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 0.625907 | 0.203 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 0.628469 | 0.202 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 0.628469 | 0.202 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 0.628669 | 0.202 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 0.629728 | 0.201 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 0.630024 | 0.201 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 0.630024 | 0.201 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 0.630024 | 0.201 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 0.631326 | 0.200 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 0.632521 | 0.199 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 0.633364 | 0.198 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 0.633364 | 0.198 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 0.633364 | 0.198 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 0.633364 | 0.198 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 0.634581 | 0.198 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 0.635029 | 0.197 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 0.635419 | 0.197 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 0.640911 | 0.193 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 0.640911 | 0.193 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 0.640911 | 0.193 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 0.641849 | 0.193 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 0.642688 | 0.192 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 0.646242 | 0.190 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 0.649027 | 0.188 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 0.649027 | 0.188 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 0.649027 | 0.188 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 0.649027 | 0.188 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 0.649027 | 0.188 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 0.649027 | 0.188 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 0.649027 | 0.188 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 0.649027 | 0.188 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 0.649027 | 0.188 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 0.649027 | 0.188 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 0.649027 | 0.188 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 0.649408 | 0.187 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 0.649408 | 0.187 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 0.651544 | 0.186 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 0.654299 | 0.184 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 0.656284 | 0.183 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 0.659650 | 0.181 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 0.660985 | 0.180 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 0.661924 | 0.179 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 0.661924 | 0.179 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 0.664021 | 0.178 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 0.664021 | 0.178 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 0.664021 | 0.178 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 0.664021 | 0.178 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 0.664021 | 0.178 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 0.664021 | 0.178 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 0.664021 | 0.178 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 0.664021 | 0.178 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 0.668365 | 0.175 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 0.668949 | 0.175 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 0.668949 | 0.175 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 0.671443 | 0.173 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 0.672055 | 0.173 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 0.672055 | 0.173 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 0.672055 | 0.173 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 0.672055 | 0.173 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 0.677532 | 0.169 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 0.677532 | 0.169 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 0.678375 | 0.169 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 0.678375 | 0.169 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 0.678573 | 0.168 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 0.681939 | 0.166 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 0.681939 | 0.166 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 0.685579 | 0.164 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 0.685783 | 0.164 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 0.685974 | 0.164 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 0.688068 | 0.162 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 0.688068 | 0.162 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 0.692117 | 0.160 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 0.692117 | 0.160 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 0.692506 | 0.160 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 0.694105 | 0.159 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 0.695520 | 0.158 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 0.699309 | 0.155 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 0.699309 | 0.155 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 0.700392 | 0.155 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 0.700973 | 0.154 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 0.701220 | 0.154 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 0.702961 | 0.153 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 0.705273 | 0.152 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 0.705273 | 0.152 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 0.705273 | 0.152 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 0.706004 | 0.151 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 0.706426 | 0.151 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 0.706426 | 0.151 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 0.708815 | 0.149 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 0.712374 | 0.147 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 0.717867 | 0.144 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 0.717867 | 0.144 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 0.717867 | 0.144 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 0.717867 | 0.144 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 0.717867 | 0.144 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 0.717867 | 0.144 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 0.719052 | 0.143 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 0.719052 | 0.143 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 0.719052 | 0.143 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 0.719067 | 0.143 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 0.723560 | 0.141 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 0.727741 | 0.138 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 0.729871 | 0.137 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 0.729924 | 0.137 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 0.729924 | 0.137 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 0.729924 | 0.137 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 0.729924 | 0.137 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 0.729924 | 0.137 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 0.731697 | 0.136 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 0.736202 | 0.133 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 0.736202 | 0.133 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 0.736202 | 0.133 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 0.740850 | 0.130 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 0.741466 | 0.130 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 0.741466 | 0.130 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 0.741466 | 0.130 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 0.741466 | 0.130 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 0.743897 | 0.128 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 0.743897 | 0.128 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 0.744437 | 0.128 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 0.751291 | 0.124 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 0.752451 | 0.124 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 0.752516 | 0.123 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 0.752516 | 0.123 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 0.752516 | 0.123 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 0.755670 | 0.122 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 0.759837 | 0.119 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 0.760248 | 0.119 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 0.762079 | 0.118 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 0.763094 | 0.117 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 0.763094 | 0.117 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 0.763094 | 0.117 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 0.763094 | 0.117 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 0.763094 | 0.117 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 0.763094 | 0.117 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 0.763094 | 0.117 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 0.763094 | 0.117 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 0.763094 | 0.117 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 0.763094 | 0.117 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 0.763094 | 0.117 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 0.767831 | 0.115 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 0.770590 | 0.113 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 0.773220 | 0.112 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 0.773220 | 0.112 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 0.773220 | 0.112 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 0.773220 | 0.112 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 0.773220 | 0.112 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 0.773220 | 0.112 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 0.775204 | 0.111 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 0.782373 | 0.107 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 0.782373 | 0.107 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 0.782914 | 0.106 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 0.782914 | 0.106 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 0.782914 | 0.106 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 0.782914 | 0.106 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 0.782914 | 0.106 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 0.782914 | 0.106 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 0.782914 | 0.106 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 0.788194 | 0.103 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 0.788482 | 0.103 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 0.789339 | 0.103 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 0.789339 | 0.103 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 0.789339 | 0.103 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 0.789339 | 0.103 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 0.789339 | 0.103 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 0.792195 | 0.101 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 0.796109 | 0.099 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 0.798509 | 0.098 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 0.798606 | 0.098 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 0.801079 | 0.096 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 0.801079 | 0.096 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 0.801079 | 0.096 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 0.801079 | 0.096 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 0.801079 | 0.096 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 0.802685 | 0.095 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 0.802685 | 0.095 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 0.802685 | 0.095 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 0.803519 | 0.095 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 0.809072 | 0.092 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 0.809584 | 0.092 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 0.809584 | 0.092 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 0.813682 | 0.090 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 0.813682 | 0.090 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 0.813682 | 0.090 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 0.816223 | 0.088 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 0.817678 | 0.087 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 0.817710 | 0.087 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 0.817726 | 0.087 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 0.817726 | 0.087 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 0.817726 | 0.087 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 0.817726 | 0.087 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 0.823994 | 0.084 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 0.825520 | 0.083 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 0.825520 | 0.083 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 0.825520 | 0.083 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 0.825520 | 0.083 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 0.825520 | 0.083 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 0.825520 | 0.083 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 0.826643 | 0.083 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 0.827142 | 0.082 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 0.831095 | 0.080 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 0.832981 | 0.079 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 0.832981 | 0.079 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 0.832981 | 0.079 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 0.832981 | 0.079 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 0.832981 | 0.079 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 0.832981 | 0.079 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 0.832981 | 0.079 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 0.832981 | 0.079 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 0.832981 | 0.079 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 0.832981 | 0.079 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 0.835850 | 0.078 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 0.836050 | 0.078 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 0.838318 | 0.077 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 0.838318 | 0.077 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 0.838318 | 0.077 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 0.839403 | 0.076 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 0.840124 | 0.076 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 0.840124 | 0.076 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 0.840124 | 0.076 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 0.840124 | 0.076 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 0.840124 | 0.076 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 0.840127 | 0.076 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 0.843657 | 0.074 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 0.845016 | 0.073 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 0.846961 | 0.072 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 0.846961 | 0.072 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 0.846961 | 0.072 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 0.846961 | 0.072 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 0.846961 | 0.072 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 0.849430 | 0.071 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 0.853507 | 0.069 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 0.853507 | 0.069 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 0.853507 | 0.069 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 0.853507 | 0.069 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 0.853507 | 0.069 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 0.853507 | 0.069 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 0.853507 | 0.069 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 0.853507 | 0.069 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 0.853735 | 0.069 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 0.853735 | 0.069 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 0.853735 | 0.069 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 0.853859 | 0.069 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 0.858729 | 0.066 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 0.859773 | 0.066 | 0 | 0 |
| Depurination | R-HSA-73927 | 0.859773 | 0.066 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 0.859773 | 0.066 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 0.859773 | 0.066 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 0.859773 | 0.066 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 0.859773 | 0.066 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 0.862022 | 0.064 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 0.862688 | 0.064 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 0.863450 | 0.064 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 0.863450 | 0.064 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 0.865771 | 0.063 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 0.865771 | 0.063 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 0.865771 | 0.063 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 0.865965 | 0.062 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 0.866010 | 0.062 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 0.868026 | 0.061 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 0.869895 | 0.061 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 0.869895 | 0.061 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 0.871513 | 0.060 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 0.871513 | 0.060 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 0.871513 | 0.060 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 0.871513 | 0.060 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 0.871513 | 0.060 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 0.871513 | 0.060 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 0.871513 | 0.060 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 0.871513 | 0.060 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 0.871513 | 0.060 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 0.871513 | 0.060 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 0.871513 | 0.060 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 0.871513 | 0.060 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 0.871513 | 0.060 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 0.872323 | 0.059 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 0.877010 | 0.057 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 0.877010 | 0.057 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 0.877010 | 0.057 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 0.877010 | 0.057 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 0.878423 | 0.056 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 0.878423 | 0.056 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 0.879725 | 0.056 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 0.882272 | 0.054 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 0.882272 | 0.054 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 0.882272 | 0.054 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 0.882272 | 0.054 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 0.882272 | 0.054 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 0.882272 | 0.054 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 0.884955 | 0.053 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 0.884955 | 0.053 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 0.887107 | 0.052 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 0.887309 | 0.052 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 0.887309 | 0.052 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 0.888861 | 0.051 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 0.888861 | 0.051 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 0.892131 | 0.050 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 0.892131 | 0.050 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 0.892445 | 0.049 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 0.894409 | 0.048 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 0.896747 | 0.047 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 0.897493 | 0.047 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 0.897855 | 0.047 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 0.900417 | 0.046 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 0.900417 | 0.046 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 0.901166 | 0.045 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 0.901166 | 0.045 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 0.901166 | 0.045 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 0.901166 | 0.045 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 0.901166 | 0.045 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 0.905396 | 0.043 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 0.905396 | 0.043 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 0.905396 | 0.043 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 0.905396 | 0.043 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 0.905396 | 0.043 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 0.906610 | 0.043 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 0.909445 | 0.041 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 0.909445 | 0.041 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 0.909465 | 0.041 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 0.913321 | 0.039 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 0.913321 | 0.039 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 0.917031 | 0.038 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 0.917031 | 0.038 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 0.918863 | 0.037 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 0.920923 | 0.036 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 0.921138 | 0.036 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 0.923982 | 0.034 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 0.923982 | 0.034 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 0.923982 | 0.034 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 0.923982 | 0.034 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 0.927237 | 0.033 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 0.927237 | 0.033 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 0.927237 | 0.033 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 0.928505 | 0.032 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 0.929593 | 0.032 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 0.929593 | 0.032 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 0.929593 | 0.032 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 0.929593 | 0.032 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 0.930352 | 0.031 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 0.930352 | 0.031 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 0.930352 | 0.031 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 0.933334 | 0.030 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 0.936745 | 0.028 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 0.938922 | 0.027 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 0.938922 | 0.027 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 0.938922 | 0.027 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 0.939502 | 0.027 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 0.941537 | 0.026 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 0.944041 | 0.025 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 0.944041 | 0.025 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 0.945550 | 0.024 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 0.946438 | 0.024 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 0.947157 | 0.024 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 0.948124 | 0.023 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 0.948732 | 0.023 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 0.948732 | 0.023 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 0.948732 | 0.023 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 0.948732 | 0.023 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 0.950847 | 0.022 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 0.950928 | 0.022 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 0.950928 | 0.022 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 0.954290 | 0.020 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 0.955043 | 0.020 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 0.956969 | 0.019 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 0.957364 | 0.019 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 0.958056 | 0.019 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 0.959026 | 0.018 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 0.960497 | 0.018 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 0.962267 | 0.017 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 0.963289 | 0.016 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 0.963884 | 0.016 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 0.963884 | 0.016 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 0.963884 | 0.016 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 0.964184 | 0.016 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 0.964926 | 0.016 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 0.965048 | 0.015 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 0.965891 | 0.015 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 0.966913 | 0.015 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 0.967125 | 0.015 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 0.968316 | 0.014 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 0.968316 | 0.014 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 0.968331 | 0.014 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 0.968331 | 0.014 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 0.968331 | 0.014 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 0.969465 | 0.013 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 0.969465 | 0.013 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 0.969689 | 0.013 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 0.970363 | 0.013 | 0 | 0 |
| Disease | R-HSA-1643685 | 0.971202 | 0.013 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 0.972232 | 0.012 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 0.972232 | 0.012 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 0.972232 | 0.012 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 0.972676 | 0.012 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 0.975561 | 0.011 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 0.976455 | 0.010 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 0.976697 | 0.010 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 0.976697 | 0.010 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 0.977353 | 0.010 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 0.977696 | 0.010 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 0.977696 | 0.010 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 0.978876 | 0.009 | 1 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 0.979568 | 0.009 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 0.981283 | 0.008 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 0.982086 | 0.008 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 0.982089 | 0.008 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 0.984968 | 0.007 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 0.987056 | 0.006 | 1 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 0.987109 | 0.006 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 0.987251 | 0.006 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 0.987352 | 0.006 | 0 | 0 |
| Protein folding | R-HSA-391251 | 0.988447 | 0.005 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 0.988447 | 0.005 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 0.988923 | 0.005 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 0.988942 | 0.005 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 0.989301 | 0.005 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 0.989417 | 0.005 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 0.990575 | 0.004 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 0.990575 | 0.004 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 0.990722 | 0.004 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 0.990722 | 0.004 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 0.991198 | 0.004 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 0.991502 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 0.991867 | 0.004 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 0.992474 | 0.003 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 0.993166 | 0.003 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 0.993275 | 0.003 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 0.993439 | 0.003 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 0.993750 | 0.003 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 0.994019 | 0.003 | 0 | 0 |
| Translation | R-HSA-72766 | 0.994288 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 0.994293 | 0.002 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 0.994755 | 0.002 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 0.995066 | 0.002 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 0.995198 | 0.002 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 0.995405 | 0.002 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 0.995577 | 0.002 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 0.995633 | 0.002 | 1 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 0.996470 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 0.996767 | 0.001 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 0.997214 | 0.001 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 0.997725 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 0.997913 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 0.997913 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 0.997917 | 0.001 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 0.998400 | 0.001 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 0.998649 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 0.998827 | 0.001 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 0.999209 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 0.999276 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 0.999365 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 0.999380 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 0.999534 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 0.999795 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 0.999839 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 0.999876 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 0.999936 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 0.999965 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 0.999989 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 0.999991 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 0.999993 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 0.999998 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 0.999998 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 0.999999 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 0.999999 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 0.999999 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000 | -0.000 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.000000 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.551115e-16 | 15.256 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.665335e-15 | 14.778 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.440093e-15 | 14.264 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.438494e-15 | 14.129 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.864375e-14 | 13.543 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.808065e-14 | 13.419 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.249756e-14 | 13.140 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.515411e-14 | 13.070 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.615375e-13 | 12.792 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.596501e-13 | 12.797 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.615685e-13 | 12.582 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.207701e-12 | 11.918 | 1 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.006684e-12 | 11.397 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.148015e-12 | 11.382 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 6.566525e-12 | 11.183 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.559398e-12 | 11.122 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.129830e-12 | 11.090 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.103162e-11 | 10.957 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.063294e-11 | 10.973 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.330902e-11 | 10.199 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.500067e-11 | 10.187 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.791826e-10 | 9.747 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.380185e-10 | 9.623 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.103617e-10 | 9.508 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.667839e-10 | 9.331 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 6.102531e-10 | 9.214 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 6.077713e-10 | 9.216 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.039236e-10 | 9.152 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.862827e-10 | 9.104 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.145339e-09 | 8.941 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.423753e-09 | 8.847 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.791181e-09 | 8.747 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.063305e-09 | 8.514 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.211222e-09 | 8.376 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.194563e-09 | 8.208 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.789287e-09 | 8.168 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.280760e-09 | 8.082 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.602156e-09 | 8.018 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.149017e-08 | 7.940 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.284881e-08 | 7.891 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.403396e-08 | 7.853 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.385217e-08 | 7.858 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.766550e-08 | 7.753 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.766550e-08 | 7.753 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.766550e-08 | 7.753 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.766550e-08 | 7.753 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.945553e-08 | 7.711 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.238974e-08 | 7.650 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.552305e-08 | 7.593 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.560453e-08 | 7.592 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.736944e-08 | 7.563 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.355788e-08 | 7.474 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.732914e-08 | 7.428 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.816157e-08 | 7.418 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.863674e-08 | 7.413 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.930423e-08 | 7.307 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.497457e-08 | 7.260 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.623959e-08 | 7.017 | 1 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.077351e-07 | 6.968 | 1 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.216021e-07 | 6.915 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.258434e-07 | 6.900 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.523861e-07 | 6.817 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.898866e-07 | 6.722 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.534947e-07 | 6.596 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.585740e-07 | 6.587 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.606487e-07 | 6.584 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.309970e-07 | 6.480 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.191091e-07 | 6.378 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.874017e-07 | 6.312 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.300018e-07 | 6.276 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.630881e-07 | 6.249 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.711617e-07 | 6.243 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.640308e-07 | 6.117 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.904090e-07 | 6.004 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.109613e-06 | 5.955 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.136404e-06 | 5.944 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.696699e-06 | 5.770 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.939677e-06 | 5.712 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.117768e-06 | 5.674 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.169201e-06 | 5.664 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.354883e-06 | 5.628 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.262369e-06 | 5.486 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.331173e-06 | 5.477 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.463404e-06 | 5.460 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.751331e-06 | 5.240 | 1 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.076686e-06 | 5.150 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.526989e-06 | 5.123 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.221012e-06 | 5.085 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.221012e-06 | 5.085 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.426776e-06 | 5.074 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 8.910279e-06 | 5.050 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.017557e-05 | 4.992 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.098282e-05 | 4.959 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.267218e-05 | 4.897 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.409628e-05 | 4.851 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.409628e-05 | 4.851 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.529242e-05 | 4.816 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.529242e-05 | 4.816 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.898449e-05 | 4.722 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.969398e-05 | 4.706 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.969398e-05 | 4.706 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.969398e-05 | 4.706 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.155688e-05 | 4.666 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.006640e-05 | 4.522 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.406235e-05 | 4.468 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.582898e-05 | 4.446 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.760978e-05 | 4.425 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.766477e-05 | 4.424 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.226434e-05 | 4.374 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.041460e-05 | 4.393 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.933307e-05 | 4.307 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.361347e-05 | 4.271 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.356414e-05 | 4.197 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.555442e-05 | 4.183 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.555442e-05 | 4.183 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.617760e-05 | 4.179 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.827697e-05 | 4.166 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.258264e-05 | 4.139 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.613834e-05 | 4.065 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.113493e-04 | 3.953 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.274122e-04 | 3.895 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.296944e-04 | 3.887 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.414393e-04 | 3.849 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.430479e-04 | 3.845 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.433616e-04 | 3.844 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.734747e-04 | 3.761 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.759856e-04 | 3.755 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.784454e-04 | 3.748 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.843445e-04 | 3.734 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.289482e-04 | 3.640 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.806500e-04 | 3.552 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.642662e-04 | 3.578 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.978873e-04 | 3.526 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.060385e-04 | 3.514 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.219498e-04 | 3.492 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.277390e-04 | 3.484 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.277390e-04 | 3.484 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.335754e-04 | 3.477 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.486335e-04 | 3.458 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.870465e-04 | 3.412 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.426848e-04 | 3.354 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.472212e-04 | 3.349 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.847097e-04 | 3.315 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.879404e-04 | 3.312 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.917124e-04 | 3.308 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.738365e-04 | 3.241 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.456132e-04 | 3.263 | 1 | 0 |
| Hemostasis | R-HSA-109582 | 5.932361e-04 | 3.227 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.165783e-04 | 3.210 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.922413e-04 | 3.160 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.372931e-04 | 3.132 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.502797e-04 | 3.125 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.464290e-04 | 3.072 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.327035e-04 | 3.030 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 9.482289e-04 | 3.023 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.058177e-03 | 2.975 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.088661e-03 | 2.963 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.095223e-03 | 2.960 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.099478e-03 | 2.959 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.378792e-03 | 2.861 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.312318e-03 | 2.882 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.333530e-03 | 2.875 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.378792e-03 | 2.861 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.378792e-03 | 2.861 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.379510e-03 | 2.860 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.448572e-03 | 2.839 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.589617e-03 | 2.799 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.589617e-03 | 2.799 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.722256e-03 | 2.764 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.881461e-03 | 2.726 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.916424e-03 | 2.718 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.957472e-03 | 2.708 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.999882e-03 | 2.699 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.113429e-03 | 2.675 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.113429e-03 | 2.675 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.124601e-03 | 2.673 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.199794e-03 | 2.658 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.212148e-03 | 2.655 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.212674e-03 | 2.655 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.228010e-03 | 2.652 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.382706e-03 | 2.623 | 1 | 1 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.591458e-03 | 2.586 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.908835e-03 | 2.536 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.835503e-03 | 2.547 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.570714e-03 | 2.590 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.053120e-03 | 2.515 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.101603e-03 | 2.508 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.137822e-03 | 2.503 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.233435e-03 | 2.490 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.234789e-03 | 2.490 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.276511e-03 | 2.485 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.527045e-03 | 2.453 | 1 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.533327e-03 | 2.452 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.561711e-03 | 2.448 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.561711e-03 | 2.448 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.762923e-03 | 2.424 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.987425e-03 | 2.399 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.351105e-03 | 2.361 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.421764e-03 | 2.354 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.560826e-03 | 2.341 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.628052e-03 | 2.335 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.192744e-03 | 2.285 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.265999e-03 | 2.279 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.436778e-03 | 2.265 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.759405e-03 | 2.240 | 1 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.767043e-03 | 2.170 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.091887e-03 | 2.215 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.645574e-03 | 2.177 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.320983e-03 | 2.199 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.256166e-03 | 2.139 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.905031e-03 | 2.161 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.114081e-03 | 2.214 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 7.063986e-03 | 2.151 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.256166e-03 | 2.139 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 7.285895e-03 | 2.138 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 7.285895e-03 | 2.138 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.534201e-03 | 2.123 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 7.706644e-03 | 2.113 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.950725e-03 | 2.100 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.372649e-03 | 2.077 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 9.656271e-03 | 2.015 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.031250e-02 | 1.987 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.031250e-02 | 1.987 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.040023e-02 | 1.983 | 1 | 0 |
| CaM pathway | R-HSA-111997 | 1.040023e-02 | 1.983 | 1 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.055122e-02 | 1.977 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.062467e-02 | 1.974 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.066119e-02 | 1.972 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.066119e-02 | 1.972 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.161982e-02 | 1.935 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.161982e-02 | 1.935 | 1 | 1 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.250271e-02 | 1.903 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.260055e-02 | 1.900 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.260055e-02 | 1.900 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.260055e-02 | 1.900 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.260055e-02 | 1.900 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.260055e-02 | 1.900 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.260055e-02 | 1.900 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.357932e-02 | 1.867 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.357932e-02 | 1.867 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.357932e-02 | 1.867 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.458048e-02 | 1.836 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.463138e-02 | 1.835 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.463138e-02 | 1.835 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.463138e-02 | 1.835 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.463138e-02 | 1.835 | 1 | 1 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.463138e-02 | 1.835 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.804354e-02 | 1.744 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.935991e-02 | 1.713 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.930837e-02 | 1.714 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.767259e-02 | 1.753 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.767259e-02 | 1.753 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.686435e-02 | 1.773 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.897801e-02 | 1.722 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.946832e-02 | 1.711 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.985836e-02 | 1.702 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.059769e-02 | 1.686 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.105039e-02 | 1.677 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.200564e-02 | 1.657 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.207199e-02 | 1.656 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.236278e-02 | 1.650 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.277151e-02 | 1.643 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.389523e-02 | 1.622 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.465509e-02 | 1.608 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.465509e-02 | 1.608 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.562461e-02 | 1.591 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.562461e-02 | 1.591 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.562461e-02 | 1.591 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.562461e-02 | 1.591 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.589049e-02 | 1.587 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.589049e-02 | 1.587 | 1 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.591121e-02 | 1.587 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.641627e-02 | 1.578 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.683850e-02 | 1.571 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.683850e-02 | 1.571 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.683850e-02 | 1.571 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.683850e-02 | 1.571 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.743489e-02 | 1.562 | 0 | 0 |
| Translation | R-HSA-72766 | 2.755790e-02 | 1.560 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.788865e-02 | 1.555 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.816134e-02 | 1.550 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.826130e-02 | 1.549 | 1 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.071042e-02 | 1.513 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.113340e-02 | 1.507 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.113340e-02 | 1.507 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.154454e-02 | 1.501 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.154454e-02 | 1.501 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.335798e-02 | 1.477 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.360054e-02 | 1.474 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.360054e-02 | 1.474 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.515618e-02 | 1.454 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.554754e-02 | 1.449 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.554754e-02 | 1.449 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.554754e-02 | 1.449 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.573927e-02 | 1.447 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.573927e-02 | 1.447 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.592692e-02 | 1.445 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.603122e-02 | 1.443 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.656529e-02 | 1.437 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.518502e-02 | 1.345 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.639949e-02 | 1.333 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.999407e-02 | 1.301 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.999407e-02 | 1.301 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.620486e-02 | 1.335 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.999407e-02 | 1.301 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.518502e-02 | 1.345 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.317371e-02 | 1.274 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.697861e-02 | 1.328 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.639949e-02 | 1.333 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.697861e-02 | 1.328 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.518502e-02 | 1.345 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.117159e-02 | 1.385 | 1 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.070760e-02 | 1.390 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.715151e-02 | 1.327 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.715882e-02 | 1.326 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.120973e-02 | 1.385 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 4.518502e-02 | 1.345 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.886274e-02 | 1.311 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.965448e-02 | 1.304 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.886274e-02 | 1.311 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.518502e-02 | 1.345 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.246848e-02 | 1.280 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.076275e-02 | 1.390 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.697861e-02 | 1.328 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.703559e-02 | 1.328 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.639949e-02 | 1.333 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.374777e-02 | 1.270 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.480008e-02 | 1.261 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.566013e-02 | 1.254 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.566013e-02 | 1.254 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.566013e-02 | 1.254 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.675785e-02 | 1.246 | 1 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.675845e-02 | 1.246 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.973988e-02 | 1.224 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.973988e-02 | 1.224 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.045156e-02 | 1.219 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.164494e-02 | 1.210 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.171567e-02 | 1.210 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.359049e-02 | 1.197 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.439700e-02 | 1.191 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.596310e-02 | 1.181 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.666625e-02 | 1.176 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.666625e-02 | 1.176 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.685353e-02 | 1.175 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.688791e-02 | 1.175 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.688791e-02 | 1.175 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.688791e-02 | 1.175 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.688791e-02 | 1.175 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.688791e-02 | 1.175 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.688791e-02 | 1.175 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.394100e-02 | 1.131 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 7.394100e-02 | 1.131 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.394100e-02 | 1.131 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.859578e-02 | 1.105 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.878899e-02 | 1.104 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.878899e-02 | 1.104 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.878899e-02 | 1.104 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.878899e-02 | 1.104 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.878899e-02 | 1.104 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.878899e-02 | 1.104 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.959742e-02 | 1.099 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 8.053631e-02 | 1.094 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 8.053631e-02 | 1.094 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 8.053631e-02 | 1.094 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 8.053631e-02 | 1.094 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 8.053631e-02 | 1.094 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 8.053631e-02 | 1.094 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 8.053631e-02 | 1.094 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 8.053631e-02 | 1.094 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.074597e-02 | 1.093 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.107226e-02 | 1.091 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.155147e-02 | 1.089 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.155147e-02 | 1.089 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 8.378991e-02 | 1.077 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.445237e-02 | 1.073 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.945976e-02 | 1.048 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 8.948435e-02 | 1.048 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 8.948435e-02 | 1.048 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.948435e-02 | 1.048 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.948435e-02 | 1.048 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.183420e-01 | 0.927 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.183420e-01 | 0.927 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 1.183420e-01 | 0.927 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.183420e-01 | 0.927 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.128919e-02 | 1.040 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.128919e-02 | 1.040 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 9.128919e-02 | 1.040 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.043193e-01 | 0.982 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.043193e-01 | 0.982 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.178148e-01 | 0.929 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.317155e-01 | 0.880 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 9.772573e-02 | 1.010 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 9.772573e-02 | 1.010 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.062613e-01 | 0.974 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.062613e-01 | 0.974 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.985949e-02 | 1.046 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.985949e-02 | 1.046 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.985949e-02 | 1.046 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.334850e-01 | 0.875 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.613376e-02 | 1.017 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.613376e-02 | 1.017 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.092762e-01 | 0.961 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.161335e-01 | 0.935 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.167085e-01 | 0.933 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.045235e-01 | 0.981 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.045235e-01 | 0.981 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.343477e-01 | 0.872 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.317155e-01 | 0.880 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.043193e-01 | 0.982 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.241559e-01 | 0.906 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.621580e-02 | 1.017 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.194778e-01 | 0.923 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 9.959956e-02 | 1.002 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.043193e-01 | 0.982 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.043193e-01 | 0.982 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.043193e-01 | 0.982 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.062613e-01 | 0.974 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.613376e-02 | 1.017 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.186015e-01 | 0.926 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.613376e-02 | 1.017 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.231737e-01 | 0.909 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.026078e-01 | 0.989 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.285920e-01 | 0.891 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.183420e-01 | 0.927 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 1.183420e-01 | 0.927 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 9.128919e-02 | 1.040 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.317155e-01 | 0.880 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.334850e-01 | 0.875 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.334850e-01 | 0.875 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.128919e-02 | 1.040 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.285920e-01 | 0.891 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.303910e-01 | 0.885 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.312492e-01 | 0.882 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.072654e-01 | 0.970 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.334850e-01 | 0.875 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.043193e-01 | 0.982 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.317155e-01 | 0.880 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.241559e-01 | 0.906 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.303910e-01 | 0.885 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.186015e-01 | 0.926 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.208218e-01 | 0.918 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 9.128919e-02 | 1.040 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.985949e-02 | 1.046 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.156870e-01 | 0.937 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.185188e-01 | 0.926 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.178148e-01 | 0.929 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.347327e-01 | 0.871 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.364979e-01 | 0.865 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.377788e-01 | 0.861 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.377788e-01 | 0.861 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.411418e-01 | 0.850 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.412211e-01 | 0.850 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.430484e-01 | 0.845 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.459655e-01 | 0.836 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.459655e-01 | 0.836 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.459655e-01 | 0.836 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.459655e-01 | 0.836 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.478526e-01 | 0.830 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.528308e-01 | 0.816 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.528308e-01 | 0.816 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.530405e-01 | 0.815 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.539102e-01 | 0.813 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.545953e-01 | 0.811 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.545953e-01 | 0.811 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.545953e-01 | 0.811 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.545953e-01 | 0.811 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.567815e-01 | 0.805 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.602360e-01 | 0.795 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.605126e-01 | 0.794 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.605126e-01 | 0.794 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.605126e-01 | 0.794 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.605424e-01 | 0.794 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.609008e-01 | 0.793 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 1.628172e-01 | 0.788 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.628172e-01 | 0.788 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.652781e-01 | 0.782 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.662818e-01 | 0.779 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.689051e-01 | 0.772 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.726654e-01 | 0.763 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.729924e-01 | 0.762 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.753084e-01 | 0.756 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.753084e-01 | 0.756 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.755386e-01 | 0.756 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.770462e-01 | 0.752 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 1.825736e-01 | 0.739 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.833415e-01 | 0.737 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.835480e-01 | 0.736 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.853173e-01 | 0.732 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.853173e-01 | 0.732 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.893601e-01 | 0.723 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.903079e-01 | 0.721 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.903079e-01 | 0.721 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.903079e-01 | 0.721 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.903079e-01 | 0.721 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.226973e-01 | 0.652 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.226973e-01 | 0.652 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.226973e-01 | 0.652 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.226973e-01 | 0.652 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.226973e-01 | 0.652 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.226973e-01 | 0.652 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.226973e-01 | 0.652 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.546655e-01 | 0.594 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.546655e-01 | 0.594 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.546655e-01 | 0.594 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.546655e-01 | 0.594 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.853208e-01 | 0.545 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.853208e-01 | 0.545 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.853208e-01 | 0.545 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 2.853208e-01 | 0.545 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.147170e-01 | 0.502 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.147170e-01 | 0.502 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.147170e-01 | 0.502 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.429058e-01 | 0.465 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.429058e-01 | 0.465 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.429058e-01 | 0.465 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.429058e-01 | 0.465 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.429058e-01 | 0.465 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.429058e-01 | 0.465 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.429058e-01 | 0.465 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.207547e-01 | 0.656 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.207547e-01 | 0.656 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 2.361277e-01 | 0.627 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.699368e-01 | 0.432 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.699368e-01 | 0.432 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.699368e-01 | 0.432 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.699368e-01 | 0.432 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.699368e-01 | 0.432 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.699368e-01 | 0.432 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.938497e-01 | 0.713 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.670074e-01 | 0.573 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.045027e-01 | 0.689 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.045027e-01 | 0.689 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.045027e-01 | 0.689 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.261860e-01 | 0.646 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.978746e-01 | 0.526 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.594499e-01 | 0.586 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.014380e-01 | 0.521 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.098196e-01 | 0.509 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.244414e-01 | 0.649 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.324405e-01 | 0.634 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.107894e-01 | 0.508 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 3.387732e-01 | 0.470 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.515554e-01 | 0.599 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.546655e-01 | 0.594 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 2.546655e-01 | 0.594 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.207547e-01 | 0.656 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.515554e-01 | 0.599 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.737658e-01 | 0.427 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.737658e-01 | 0.427 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.464834e-01 | 0.460 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 2.546655e-01 | 0.594 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.853208e-01 | 0.545 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 3.699368e-01 | 0.432 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.824557e-01 | 0.549 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.152861e-01 | 0.667 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.387732e-01 | 0.470 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.675128e-01 | 0.573 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.824557e-01 | 0.549 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.588112e-01 | 0.445 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 3.437275e-01 | 0.464 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.478181e-01 | 0.606 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.261860e-01 | 0.646 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.152861e-01 | 0.667 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.779699e-01 | 0.556 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.853208e-01 | 0.545 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.853208e-01 | 0.545 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.853208e-01 | 0.545 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.054696e-01 | 0.687 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.429058e-01 | 0.465 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.429058e-01 | 0.465 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.361277e-01 | 0.627 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.699368e-01 | 0.432 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.515554e-01 | 0.599 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.995844e-01 | 0.700 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 3.737658e-01 | 0.427 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.160182e-01 | 0.500 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.160182e-01 | 0.500 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.501367e-01 | 0.456 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.840615e-01 | 0.416 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.606021e-01 | 0.443 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.007717e-01 | 0.697 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.387732e-01 | 0.470 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.602940e-01 | 0.443 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.699368e-01 | 0.432 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.699368e-01 | 0.432 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.978746e-01 | 0.526 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.932078e-01 | 0.714 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.371887e-01 | 0.625 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 2.932928e-01 | 0.533 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.285312e-01 | 0.483 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.546655e-01 | 0.594 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.160182e-01 | 0.500 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.160182e-01 | 0.500 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.226973e-01 | 0.652 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.226973e-01 | 0.652 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.546655e-01 | 0.594 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.147170e-01 | 0.502 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.429058e-01 | 0.465 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.699368e-01 | 0.432 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.699368e-01 | 0.432 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.644284e-01 | 0.578 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 3.737658e-01 | 0.427 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.170817e-01 | 0.499 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.537228e-01 | 0.451 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 3.603777e-01 | 0.443 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.737658e-01 | 0.427 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.218356e-01 | 0.654 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.840615e-01 | 0.416 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.848961e-01 | 0.545 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 2.045027e-01 | 0.689 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.737658e-01 | 0.427 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.737658e-01 | 0.427 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.207547e-01 | 0.656 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.261860e-01 | 0.646 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.389807e-01 | 0.470 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.025806e-01 | 0.693 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.389807e-01 | 0.470 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.115023e-01 | 0.507 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.125412e-01 | 0.673 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.546655e-01 | 0.594 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.546655e-01 | 0.594 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.853208e-01 | 0.545 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.147170e-01 | 0.502 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.273971e-01 | 0.485 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.634476e-01 | 0.579 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.953239e-01 | 0.530 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.501367e-01 | 0.456 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 3.093397e-01 | 0.510 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 2.932928e-01 | 0.533 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.160182e-01 | 0.500 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.734101e-01 | 0.563 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.338411e-01 | 0.476 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.670074e-01 | 0.573 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.135387e-01 | 0.504 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.371887e-01 | 0.625 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.462537e-01 | 0.609 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.853208e-01 | 0.545 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.853208e-01 | 0.545 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 3.147170e-01 | 0.502 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.054696e-01 | 0.687 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.207547e-01 | 0.656 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.978746e-01 | 0.526 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.932928e-01 | 0.533 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.558331e-01 | 0.592 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.196369e-01 | 0.495 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.515554e-01 | 0.599 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.108946e-01 | 0.676 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.263088e-01 | 0.486 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 3.166938e-01 | 0.499 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.771364e-01 | 0.557 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.429058e-01 | 0.465 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.828410e-01 | 0.548 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.462537e-01 | 0.609 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.727895e-01 | 0.429 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.578294e-01 | 0.446 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.978746e-01 | 0.526 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.361277e-01 | 0.627 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.285312e-01 | 0.483 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.437275e-01 | 0.464 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.614784e-01 | 0.442 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.921197e-01 | 0.534 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.273971e-01 | 0.485 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 2.828410e-01 | 0.548 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.699368e-01 | 0.432 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.207547e-01 | 0.656 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.125412e-01 | 0.673 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.828410e-01 | 0.548 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.830388e-01 | 0.417 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.273971e-01 | 0.485 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.007471e-01 | 0.522 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.046466e-01 | 0.516 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 3.885765e-01 | 0.411 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.885765e-01 | 0.411 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.952862e-01 | 0.403 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.952862e-01 | 0.403 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.954563e-01 | 0.403 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.958573e-01 | 0.402 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.958573e-01 | 0.402 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.958573e-01 | 0.402 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.958573e-01 | 0.402 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.958573e-01 | 0.402 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.958573e-01 | 0.402 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.958573e-01 | 0.402 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.965878e-01 | 0.402 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.054339e-01 | 0.392 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.064562e-01 | 0.391 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.175641e-01 | 0.379 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.175641e-01 | 0.379 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.177136e-01 | 0.379 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.177136e-01 | 0.379 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.177136e-01 | 0.379 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.207130e-01 | 0.376 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.207130e-01 | 0.376 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.207130e-01 | 0.376 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.207130e-01 | 0.376 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.207130e-01 | 0.376 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.207130e-01 | 0.376 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.207130e-01 | 0.376 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.207130e-01 | 0.376 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.286032e-01 | 0.368 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.320171e-01 | 0.364 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.320171e-01 | 0.364 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.320171e-01 | 0.364 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.327184e-01 | 0.364 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.342814e-01 | 0.362 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.382506e-01 | 0.358 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.418897e-01 | 0.355 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.419422e-01 | 0.355 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.419422e-01 | 0.355 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.419422e-01 | 0.355 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.422162e-01 | 0.354 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.445475e-01 | 0.352 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.445475e-01 | 0.352 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.445475e-01 | 0.352 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.445475e-01 | 0.352 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 4.445475e-01 | 0.352 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.445475e-01 | 0.352 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.445475e-01 | 0.352 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.445475e-01 | 0.352 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.445475e-01 | 0.352 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.461307e-01 | 0.351 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 4.461307e-01 | 0.351 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 4.461307e-01 | 0.351 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.581142e-01 | 0.339 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.600457e-01 | 0.337 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.602505e-01 | 0.337 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.612439e-01 | 0.336 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.612439e-01 | 0.336 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.616198e-01 | 0.336 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.674028e-01 | 0.330 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.674028e-01 | 0.330 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.674028e-01 | 0.330 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.674028e-01 | 0.330 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.674028e-01 | 0.330 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.674028e-01 | 0.330 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.674028e-01 | 0.330 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.682910e-01 | 0.329 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.693273e-01 | 0.329 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.719462e-01 | 0.326 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.719462e-01 | 0.326 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.719462e-01 | 0.326 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.737546e-01 | 0.324 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.737546e-01 | 0.324 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.737546e-01 | 0.324 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.745474e-01 | 0.324 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.746417e-01 | 0.324 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 4.825872e-01 | 0.316 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.872508e-01 | 0.312 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.872508e-01 | 0.312 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.872508e-01 | 0.312 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.872508e-01 | 0.312 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 4.873083e-01 | 0.312 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.873083e-01 | 0.312 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.893189e-01 | 0.310 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.893189e-01 | 0.310 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.893189e-01 | 0.310 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.893189e-01 | 0.310 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.893189e-01 | 0.310 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.893189e-01 | 0.310 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.893189e-01 | 0.310 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.893189e-01 | 0.310 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 4.893189e-01 | 0.310 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 4.893189e-01 | 0.310 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.893189e-01 | 0.310 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.893189e-01 | 0.310 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.893189e-01 | 0.310 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.893189e-01 | 0.310 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.893189e-01 | 0.310 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.893189e-01 | 0.310 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.893189e-01 | 0.310 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.893189e-01 | 0.310 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.904911e-01 | 0.309 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.962057e-01 | 0.304 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 5.005287e-01 | 0.301 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.005287e-01 | 0.301 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.034491e-01 | 0.298 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.034491e-01 | 0.298 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.061643e-01 | 0.296 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.078452e-01 | 0.294 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.103345e-01 | 0.292 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.103345e-01 | 0.292 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.103345e-01 | 0.292 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.103345e-01 | 0.292 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 5.135833e-01 | 0.289 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.135833e-01 | 0.289 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 5.135833e-01 | 0.289 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.135833e-01 | 0.289 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.135833e-01 | 0.289 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.135833e-01 | 0.289 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 5.137341e-01 | 0.289 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.137988e-01 | 0.289 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.139291e-01 | 0.289 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 5.169051e-01 | 0.287 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.206743e-01 | 0.283 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.239046e-01 | 0.281 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 5.264106e-01 | 0.279 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.264106e-01 | 0.279 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.304865e-01 | 0.275 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.304865e-01 | 0.275 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.304865e-01 | 0.275 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.304865e-01 | 0.275 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.304865e-01 | 0.275 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.304865e-01 | 0.275 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.304865e-01 | 0.275 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.304865e-01 | 0.275 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 5.304865e-01 | 0.275 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 5.304865e-01 | 0.275 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.304865e-01 | 0.275 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.304865e-01 | 0.275 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.304865e-01 | 0.275 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.304865e-01 | 0.275 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.304865e-01 | 0.275 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.336540e-01 | 0.273 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.339572e-01 | 0.272 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.339572e-01 | 0.272 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.390071e-01 | 0.268 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.390071e-01 | 0.268 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 5.438887e-01 | 0.264 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.481004e-01 | 0.261 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.481004e-01 | 0.261 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.498103e-01 | 0.260 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.498103e-01 | 0.260 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.498103e-01 | 0.260 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.498103e-01 | 0.260 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.498103e-01 | 0.260 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.498103e-01 | 0.260 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.498103e-01 | 0.260 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.498103e-01 | 0.260 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.498103e-01 | 0.260 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.498103e-01 | 0.260 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.498103e-01 | 0.260 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.498103e-01 | 0.260 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.498103e-01 | 0.260 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.498103e-01 | 0.260 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.498103e-01 | 0.260 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.498103e-01 | 0.260 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.536964e-01 | 0.257 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.536964e-01 | 0.257 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.593814e-01 | 0.252 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.683400e-01 | 0.245 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.683400e-01 | 0.245 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.683400e-01 | 0.245 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 5.683400e-01 | 0.245 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.683400e-01 | 0.245 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.683400e-01 | 0.245 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.729296e-01 | 0.242 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 5.729770e-01 | 0.242 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.753880e-01 | 0.240 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 5.753880e-01 | 0.240 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.774512e-01 | 0.238 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.822221e-01 | 0.235 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.861080e-01 | 0.232 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 5.861080e-01 | 0.232 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 5.861080e-01 | 0.232 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.861080e-01 | 0.232 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 5.861080e-01 | 0.232 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.861080e-01 | 0.232 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.870401e-01 | 0.231 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.870401e-01 | 0.231 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.870401e-01 | 0.231 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.885745e-01 | 0.230 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 5.945533e-01 | 0.226 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.984536e-01 | 0.223 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.984536e-01 | 0.223 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 5.984536e-01 | 0.223 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.984536e-01 | 0.223 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.984536e-01 | 0.223 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.031457e-01 | 0.220 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.031457e-01 | 0.220 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.031457e-01 | 0.220 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.031457e-01 | 0.220 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.031457e-01 | 0.220 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.031457e-01 | 0.220 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.031457e-01 | 0.220 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.095817e-01 | 0.215 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.096282e-01 | 0.215 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.098110e-01 | 0.215 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.194831e-01 | 0.208 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.194831e-01 | 0.208 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.194831e-01 | 0.208 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.194831e-01 | 0.208 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.194831e-01 | 0.208 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.194831e-01 | 0.208 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.194831e-01 | 0.208 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.194831e-01 | 0.208 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.194831e-01 | 0.208 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.194831e-01 | 0.208 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.194831e-01 | 0.208 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.205644e-01 | 0.207 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.205644e-01 | 0.207 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.205644e-01 | 0.207 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.206581e-01 | 0.207 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.278887e-01 | 0.202 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.312627e-01 | 0.200 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.351488e-01 | 0.197 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.351488e-01 | 0.197 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.351488e-01 | 0.197 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.351488e-01 | 0.197 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 6.351488e-01 | 0.197 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.351488e-01 | 0.197 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 6.351488e-01 | 0.197 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.351488e-01 | 0.197 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.351488e-01 | 0.197 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.351488e-01 | 0.197 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.351488e-01 | 0.197 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.353551e-01 | 0.197 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.360383e-01 | 0.197 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.360383e-01 | 0.197 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.360383e-01 | 0.197 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 6.445025e-01 | 0.191 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.498628e-01 | 0.187 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.501705e-01 | 0.187 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.501705e-01 | 0.187 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.501705e-01 | 0.187 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.501705e-01 | 0.187 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.501705e-01 | 0.187 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.501705e-01 | 0.187 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.501705e-01 | 0.187 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.501705e-01 | 0.187 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.501705e-01 | 0.187 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.501705e-01 | 0.187 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.501705e-01 | 0.187 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.518843e-01 | 0.186 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.519505e-01 | 0.186 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.519505e-01 | 0.186 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 6.528267e-01 | 0.185 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.528267e-01 | 0.185 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.619429e-01 | 0.179 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.619429e-01 | 0.179 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.619429e-01 | 0.179 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.619429e-01 | 0.179 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.619429e-01 | 0.179 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.619429e-01 | 0.179 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.645746e-01 | 0.177 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.645746e-01 | 0.177 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 6.645746e-01 | 0.177 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.645746e-01 | 0.177 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.645746e-01 | 0.177 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 6.645746e-01 | 0.177 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.645746e-01 | 0.177 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.645746e-01 | 0.177 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.645746e-01 | 0.177 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.690540e-01 | 0.175 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.780816e-01 | 0.169 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.783865e-01 | 0.169 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.783865e-01 | 0.169 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.783865e-01 | 0.169 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.783865e-01 | 0.169 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.783865e-01 | 0.169 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.783865e-01 | 0.169 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.783865e-01 | 0.169 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.799380e-01 | 0.168 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.812344e-01 | 0.167 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 6.812344e-01 | 0.167 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.813507e-01 | 0.167 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.847196e-01 | 0.164 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.847196e-01 | 0.164 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.905379e-01 | 0.161 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.905379e-01 | 0.161 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.916304e-01 | 0.160 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.916304e-01 | 0.160 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.916304e-01 | 0.160 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.916304e-01 | 0.160 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 6.916304e-01 | 0.160 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 6.916304e-01 | 0.160 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.916304e-01 | 0.160 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.916304e-01 | 0.160 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.993074e-01 | 0.155 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.996167e-01 | 0.155 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.998252e-01 | 0.155 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.043297e-01 | 0.152 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.043297e-01 | 0.152 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.043297e-01 | 0.152 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 7.084734e-01 | 0.150 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.084734e-01 | 0.150 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.143562e-01 | 0.146 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 7.165068e-01 | 0.145 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.165068e-01 | 0.145 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.165068e-01 | 0.145 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.165068e-01 | 0.145 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.165068e-01 | 0.145 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 7.165068e-01 | 0.145 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.165068e-01 | 0.145 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.165068e-01 | 0.145 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.165068e-01 | 0.145 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.171108e-01 | 0.144 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.171108e-01 | 0.144 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.171108e-01 | 0.144 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.171961e-01 | 0.144 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.171961e-01 | 0.144 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.229196e-01 | 0.141 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.233626e-01 | 0.141 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.244883e-01 | 0.140 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.255322e-01 | 0.139 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.255322e-01 | 0.139 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.255322e-01 | 0.139 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 7.255322e-01 | 0.139 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.279911e-01 | 0.138 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.281831e-01 | 0.138 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.281831e-01 | 0.138 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.281831e-01 | 0.138 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.281831e-01 | 0.138 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.281831e-01 | 0.138 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.281831e-01 | 0.138 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.281831e-01 | 0.138 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.281831e-01 | 0.138 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.281831e-01 | 0.138 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.281831e-01 | 0.138 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.294288e-01 | 0.137 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.337405e-01 | 0.134 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.353951e-01 | 0.133 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.393792e-01 | 0.131 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.393792e-01 | 0.131 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.393792e-01 | 0.131 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.393792e-01 | 0.131 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.393792e-01 | 0.131 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.393792e-01 | 0.131 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 7.393792e-01 | 0.131 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.393792e-01 | 0.131 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.393792e-01 | 0.131 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.412618e-01 | 0.130 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.417391e-01 | 0.130 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.428129e-01 | 0.129 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.470294e-01 | 0.127 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.470294e-01 | 0.127 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.495312e-01 | 0.125 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.495312e-01 | 0.125 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.495312e-01 | 0.125 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.501147e-01 | 0.125 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.501147e-01 | 0.125 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.501147e-01 | 0.125 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.501147e-01 | 0.125 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.501147e-01 | 0.125 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.501147e-01 | 0.125 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.501147e-01 | 0.125 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.501147e-01 | 0.125 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 7.501147e-01 | 0.125 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.501147e-01 | 0.125 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.526983e-01 | 0.123 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.526983e-01 | 0.123 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.604087e-01 | 0.119 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.604087e-01 | 0.119 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.604087e-01 | 0.119 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.604087e-01 | 0.119 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.604087e-01 | 0.119 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.604087e-01 | 0.119 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.604087e-01 | 0.119 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 7.610110e-01 | 0.119 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.637423e-01 | 0.117 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.691187e-01 | 0.114 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.702792e-01 | 0.113 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.702792e-01 | 0.113 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.702792e-01 | 0.113 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.702792e-01 | 0.113 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.702792e-01 | 0.113 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.702792e-01 | 0.113 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.702792e-01 | 0.113 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.717037e-01 | 0.113 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.787050e-01 | 0.109 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.787050e-01 | 0.109 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.790231e-01 | 0.108 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.797436e-01 | 0.108 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.797436e-01 | 0.108 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.797436e-01 | 0.108 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.797436e-01 | 0.108 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.797436e-01 | 0.108 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.846735e-01 | 0.105 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.847736e-01 | 0.105 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.888187e-01 | 0.103 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.888187e-01 | 0.103 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.888187e-01 | 0.103 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.921452e-01 | 0.101 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.921452e-01 | 0.101 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.921452e-01 | 0.101 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.921452e-01 | 0.101 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.975203e-01 | 0.098 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.975203e-01 | 0.098 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.985913e-01 | 0.098 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.048597e-01 | 0.094 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.058640e-01 | 0.094 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.058640e-01 | 0.094 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.058640e-01 | 0.094 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.058640e-01 | 0.094 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.058640e-01 | 0.094 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.058640e-01 | 0.094 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.058640e-01 | 0.094 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.058640e-01 | 0.094 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.087312e-01 | 0.092 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.087312e-01 | 0.092 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.087312e-01 | 0.092 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.116937e-01 | 0.091 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.116937e-01 | 0.091 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.138643e-01 | 0.089 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.138643e-01 | 0.089 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.138643e-01 | 0.089 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.168782e-01 | 0.088 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.215354e-01 | 0.085 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.215354e-01 | 0.085 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.215354e-01 | 0.085 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.215354e-01 | 0.085 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.215354e-01 | 0.085 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.215354e-01 | 0.085 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.215354e-01 | 0.085 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.215354e-01 | 0.085 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.220847e-01 | 0.085 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.220847e-01 | 0.085 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.226356e-01 | 0.085 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.226356e-01 | 0.085 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.255483e-01 | 0.083 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.264388e-01 | 0.083 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.282301e-01 | 0.082 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.282301e-01 | 0.082 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.288908e-01 | 0.082 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.288908e-01 | 0.082 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.288908e-01 | 0.082 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.293979e-01 | 0.081 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.357111e-01 | 0.078 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.357111e-01 | 0.078 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.357111e-01 | 0.078 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.359434e-01 | 0.078 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.359434e-01 | 0.078 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.359434e-01 | 0.078 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.359434e-01 | 0.078 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.359434e-01 | 0.078 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.359434e-01 | 0.078 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.359434e-01 | 0.078 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.359434e-01 | 0.078 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.359434e-01 | 0.078 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.359762e-01 | 0.078 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.386832e-01 | 0.076 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.386832e-01 | 0.076 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.386832e-01 | 0.076 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.389446e-01 | 0.076 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.427058e-01 | 0.074 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.427058e-01 | 0.074 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.427058e-01 | 0.074 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.427058e-01 | 0.074 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.427058e-01 | 0.074 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.440718e-01 | 0.074 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.440718e-01 | 0.074 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.440718e-01 | 0.074 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.440718e-01 | 0.074 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 8.440718e-01 | 0.074 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.488184e-01 | 0.071 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 8.491898e-01 | 0.071 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.491898e-01 | 0.071 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.491898e-01 | 0.071 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.491898e-01 | 0.071 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.491898e-01 | 0.071 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.554070e-01 | 0.068 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.554070e-01 | 0.068 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.554070e-01 | 0.068 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.554070e-01 | 0.068 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 8.554070e-01 | 0.068 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.585763e-01 | 0.066 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.613682e-01 | 0.065 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.613682e-01 | 0.065 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.613682e-01 | 0.065 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 8.613682e-01 | 0.065 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.613682e-01 | 0.065 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.613682e-01 | 0.065 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.631303e-01 | 0.064 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.642058e-01 | 0.063 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.646047e-01 | 0.063 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.648739e-01 | 0.063 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.670839e-01 | 0.062 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.670839e-01 | 0.062 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.670839e-01 | 0.062 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.680007e-01 | 0.061 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.686761e-01 | 0.061 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.725644e-01 | 0.059 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.725644e-01 | 0.059 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.725644e-01 | 0.059 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.725644e-01 | 0.059 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.725644e-01 | 0.059 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.742978e-01 | 0.058 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 8.759976e-01 | 0.057 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.778192e-01 | 0.057 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.778192e-01 | 0.057 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.778192e-01 | 0.057 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.794104e-01 | 0.056 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.828576e-01 | 0.054 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.828576e-01 | 0.054 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.839464e-01 | 0.054 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.876886e-01 | 0.052 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.876886e-01 | 0.052 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 8.876886e-01 | 0.052 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.923206e-01 | 0.049 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.923206e-01 | 0.049 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.923206e-01 | 0.049 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.923206e-01 | 0.049 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.923206e-01 | 0.049 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.949892e-01 | 0.048 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.953981e-01 | 0.048 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.953981e-01 | 0.048 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.953981e-01 | 0.048 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 8.967618e-01 | 0.047 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.967618e-01 | 0.047 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.967618e-01 | 0.047 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.984476e-01 | 0.047 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.010201e-01 | 0.045 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 9.033522e-01 | 0.044 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.051030e-01 | 0.043 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.051053e-01 | 0.043 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.071438e-01 | 0.042 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.081963e-01 | 0.042 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.090178e-01 | 0.041 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.090178e-01 | 0.041 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.090178e-01 | 0.041 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.090178e-01 | 0.041 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.100878e-01 | 0.041 | 1 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.121860e-01 | 0.040 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.127712e-01 | 0.040 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.163701e-01 | 0.038 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.163701e-01 | 0.038 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.163701e-01 | 0.038 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.163701e-01 | 0.038 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.198207e-01 | 0.036 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.198207e-01 | 0.036 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.198367e-01 | 0.036 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.198367e-01 | 0.036 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.198367e-01 | 0.036 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.222827e-01 | 0.035 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.231291e-01 | 0.035 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.263012e-01 | 0.033 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.276404e-01 | 0.033 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.293425e-01 | 0.032 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.293425e-01 | 0.032 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.314186e-01 | 0.031 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.322586e-01 | 0.030 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.347231e-01 | 0.029 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.350545e-01 | 0.029 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.356080e-01 | 0.029 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.362159e-01 | 0.029 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.377351e-01 | 0.028 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.377351e-01 | 0.028 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.403052e-01 | 0.027 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.403052e-01 | 0.027 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.411458e-01 | 0.026 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.427695e-01 | 0.026 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.427695e-01 | 0.026 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.427695e-01 | 0.026 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.427695e-01 | 0.026 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.427695e-01 | 0.026 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.427695e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.431500e-01 | 0.025 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.450891e-01 | 0.025 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.451321e-01 | 0.025 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.451321e-01 | 0.025 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.451321e-01 | 0.025 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.451321e-01 | 0.025 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.451321e-01 | 0.025 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.469653e-01 | 0.024 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.473973e-01 | 0.023 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.473973e-01 | 0.023 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.476087e-01 | 0.023 | 1 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.495692e-01 | 0.022 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.495692e-01 | 0.022 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.513238e-01 | 0.022 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.516515e-01 | 0.022 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.516515e-01 | 0.022 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.516515e-01 | 0.022 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.519845e-01 | 0.021 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.535398e-01 | 0.021 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.536479e-01 | 0.021 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.536479e-01 | 0.021 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.573973e-01 | 0.019 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.577842e-01 | 0.019 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.591568e-01 | 0.018 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.591568e-01 | 0.018 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.613105e-01 | 0.017 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.624611e-01 | 0.017 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.624611e-01 | 0.017 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.624611e-01 | 0.017 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.639501e-01 | 0.016 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.654984e-01 | 0.015 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.654984e-01 | 0.015 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.664162e-01 | 0.015 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.669238e-01 | 0.015 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.675877e-01 | 0.014 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.691598e-01 | 0.014 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.691598e-01 | 0.014 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.699091e-01 | 0.013 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.718921e-01 | 0.012 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.720610e-01 | 0.012 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.732156e-01 | 0.012 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.736906e-01 | 0.012 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.738181e-01 | 0.012 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.738321e-01 | 0.012 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.739406e-01 | 0.011 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.743225e-01 | 0.011 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.743225e-01 | 0.011 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.746469e-01 | 0.011 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.753838e-01 | 0.011 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.762303e-01 | 0.010 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.764012e-01 | 0.010 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.764012e-01 | 0.010 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.773767e-01 | 0.010 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.775153e-01 | 0.010 | 1 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.777195e-01 | 0.010 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.783633e-01 | 0.009 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.836100e-01 | 0.007 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.851694e-01 | 0.006 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.858478e-01 | 0.006 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.863710e-01 | 0.006 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.863710e-01 | 0.006 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.874139e-01 | 0.006 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.889666e-01 | 0.005 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.889666e-01 | 0.005 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.892027e-01 | 0.005 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.924269e-01 | 0.003 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.932246e-01 | 0.003 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.935284e-01 | 0.003 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.937101e-01 | 0.003 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.943254e-01 | 0.002 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.945038e-01 | 0.002 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.949712e-01 | 0.002 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.950468e-01 | 0.002 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.953756e-01 | 0.002 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.956032e-01 | 0.002 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.968984e-01 | 0.001 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.971502e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.976941e-01 | 0.001 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.988781e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.989247e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.989694e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.995264e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.995599e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.995948e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.996990e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.996990e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.996991e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999549e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999734e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999781e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999848e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999888e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999986e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999997e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |